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Summary 
Burkholderia cenocepacia is a member of the Burkholderia cepacia complex (Bcc), a 
group of 20 closely related species, which are important opportunistic human 
pathogens but are also a rich source for bioactive secondary metabolites that show 
great potential for biotechnological applications. Nevertheless, safety concerns 
because of the potential virulence of many Bcc members have hampered the 
development of Burkholderia for biotechnological applications. Although bacteria are 
unicellular organisms they constantly interact with other bacteria in their vicinity by 
means of cell-cell communication systems which rely on small signalling molecules 
which accumulate in the environment as a function of their population densities. 
When a certain threshold concentration is reached, the so- called “quorum”, the 
signaling molecules bind to their cognate receptors, which in turn activate or repress 
target gene expression. These cell-cell communication systems are commonly 
referred to as quorum sensing systems.  
Previous work has shown that in many Burkholderia strains the production of 
antibiotic secondary metabolites is regulated by N-acyl homoserine lactone (AHLs)-
dependent quorum sensing systems. The CepIR quorum sensing system, which is 
present in all Bcc species, was shown to control the production of diverse antifungal 
compounds, including pyrrolnitrin in Burkholderia lata, Burkholderia ambifaria and 
Burkholderia pyrrocinia, enacyloxin in B. ambifaria and an occidiofungin-like cluster in 
B. ambifaria. 
Many bioactive natural products are synthesized by polyketide synthases (PKS) or 
non-ribosomal peptide synthetases (NRPS). NRPS enzymes consist of a minimum of 
three domains. The adenylation (A) domain recognizes and activates the amino acid 
substrate which is then transferred and covalently bound to the thiolation (T) domain. 
Peptide bond formation between T domain bound amino acids from two adjacent 
modules is catalyzed by the condensation (C) domain. The growing peptide chain is 
normally released from the last module in the NRPS assembly line via a thioesterase 
(TE) or a reductase (R) domain. 
In this thesis I characterized the genetic locus responsible for antifungal activity of B. 
cenocepacia H111 and elucidated the structure of the main antifungal agent 
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produced by this organism. Furthermore, the regulatory network which underlies 
antifungal activity has been analysed.  
My work showed that antifungal activity of B. cenocepacia H111 is dependent on the 
CepIR quorum sensing system and the LuxR solo CepR2. Furthermore, I could 
demonstrate that an NRPS-like gene cluster, named the ham (H111 antifungal 
metabolite) gene cluster, produces fragin, the main antifungal metabolite of B. 
cenocepacia H111. Fragin belongs to the rare class of nitrosohydroxylamine natural 
products and is active against fungi, yeast and Gram-positive bacteria because of its 
metal chelating activity. During the course of the study it became apparent, that the 
ham cluster also produces valazole, another nitrosohydroxylamine which is 
structurally similar to fragin. Valazole is a novel signaling molecule that regulates its 
own production and the biosynthesis of fragin. It also controls expression of several 
genes involved in metal transport and homeostasis or which rely on metals for their 
enzymatic activity.  
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Zusammenfassung  
Burkholderia cenocepacia ist ein Mtiglied des Burkholderia cepacia Komplexes 
(Burkholderia cepacia complex; Bcc), einer Gruppe von 20 eng verwandten 
bakteriellen Spezies, welche opportunistische Humanpathogene sind, aber auch eine 
reiche Quelle für bioaktive Sekundärmetabolite mit grossem Potential für 
biotechnologische Anwendungen. Die Entwicklung von Burkholderien für 
biotechnologische Anwendungen wurde aufgrund von Sicherheitsbedenken ob der 
potentiellen Virulenz vieler Mitglieder des Bcc erschwert. Obwohl Bakterien 
unizelluläre Organismen sind, interagieren sie ständing mit Bakterien in ihrer 
unmittelbaren Nähe. Dies geschieht mit Hilfe von Zell-Zell Kommunikationssystem 
welche Signalmoleküle verwenden, die in der Umgebung als Funktion der 
Populationsdichte akkumulieren. Wenn ein bestimmter Schwellenwert in der 
Konzentration erreicht wird, genannt “Quorum”, binden die Signalmoleküle and 
Rezeptoren, welche wiederum die Expression bestimmter Gene aktivieren oder 
reprimieren. Dies Zell-Zell Kommunikationssysteme warden gewöhnlich als Quorum 
Sensing Systeme bezeichnet. 
Frühere Arbeiten haben gezeigt, dass in vielen Burkholderia Stämmen die Produktion 
von Antibiotika über N-acyl homoserine lactone (AHL)-abhängige Quorum Sensing 
Systeme gesteuert wird. Das CepIR Quorum Sensing system, welches von allen 
Spezies des Bcc verwendet wird, steuert die Produktion verschiedener antifungieller 
Naturstoffe. Darunter befinden sich Pyrrolnitrin, welches von Burkholderia lata, 
Burkholderia ambifaria und Burkholderia pyrrocinia produziert wird, Enacyloxin 
welches von B. ambifaria produziert wird und Occidiofungin-ähnliche Stoffe welche 
ebenfalls von B. ambifaria produziert werden.  
Viele bioaktive Naturstoffe werden von Polyketidsynthasen (PKS) oder  
nichtribosomalen Peptidesynthetasen (non-ribosomal peptide synthetases; NRPS) 
synthetisiert. NRPS Enzyme bestehen aus wenigstens drei verschiedenen 
Proteindomänen. Die Adenylierungs(A)-Domäne erkennt und aktiviert eine 
Aminosäure welche dann an die Thiolierungs(T)-Domäne transferiert und kovalent 
gebunden wird. Die Peptidbindung zwischen zwei Aminosäuren, welche an zwei 
angrenzende T-Domänen gebunden sind, wird durch die Kondensations(C)-Domäne 
katalysiert. Die wachsende Peptidkette wird schließlich vom letzten Modul des 
Zusammenfassung 
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NRPS-Enzyms mit Hilfe einer Thioesterase(TE)-Domäne oder einer Reduktase(R)-
Domäne entlassen. 
In dieser Doktorarbeit habe ich den genetischen Lokus, der für die antifungielle 
Aktivität von B. cenocepacia H111 verantwortlich ist charakterisiert, sowie die 
Strukture des antifungiellen Stoffes aufgeklärt, welcher von diesem Bakterium 
produziert wird. Des Weiteren wurde das regulatorische Netzwerk, welches 
antifungiellen Aktivität zugrunde liegt, analysiert.  
Meine Arbeit hat gezeigt, dass die antifungielle Aktivität von B. cenocepacia H111 
sowohl vom CepIR Quorum Sensing System wie auch vom solo LuxR Regulator 
CepR2 abhängig ist. Des Weiteren konnte ich zeigen, dass ein NRPS-ähnlicher 
Gencluster, genannt ham (H111 antifungieller Metabolit) Gencluster, den 
antifungiellen Metaboliten Fragin produziert. Fragin gehört zur Klasse der Nitroso-
Hydroxylamine, welche nur selten als Naturstoffe vorkommen. Fragin zeigt aufgrund 
seiner metalchelierenden Eigenschaften antibiotische Wirkung gegen Pilze, Hefe und 
grampositive Bakterien. Im Laufe dieser Studie wurde klar, dass der ham Cluster 
auch Valazole produziert. Dabei handelt es sich um ein weiters Nitrosohydroxylamine 
welches strukturell Fragin sehr ähnlich ist. Valazole ist ein bisher unbekanntes 
Signalmolekül welches seine eigene Produktion sowie die Biosynthese von Fragin 
reguliert. Es kontrolliert auch die Expression mehrerer Gene, die im Transport und 
der Homeostase von Metallen beteiligt sind oder welche Metalle für ihre 
enzymatische Aktivität benötigen. 
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Chapter I: Introduction 
 
1 Introduction 
 
1.1 The genus Burkholderia 
The genus Burkholderia is a group of ecologically and metabolically highly diverse 
Gram-negative bacteria from the Betaproteobacteria class. Currently, the genus 
consists of 90 validly named free-living species, along with several currently 
uncultivable candidate species which exist in symbiosis with plants [1-3]. Based on 
ribosomal multilocus sequence typing (rMLST), the genus can be divided into two 
major clades (Figure 1) [3]. The first clade contains the members of the Burkholderia 
cepacia complex (Bcc), the Burkholderia pseudomallei group and the two rice 
pathogens Burkholderia glumae and Burkholderia gladioli. The second clade consists 
of members of the Burkholderia xenovorans group, including members of the 
Burkholderia glathei group, which form a distinct branch in 16s rRNA-sequence 
based phylogeny trees. Burkholderia symbiotica, Burkholderia rhizoxinica and 
Burkholderia andropogonis represent unique lineages which do not closely associate 
with the two main Burkholderia clades [3]. 
.
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Figure 1: Phylogeny tree of the genus Burkholderia based on ribosomal multilocus sequence 
typing (rMLST). Type strains are shown in bold letters. Figure is taken from Depoorter and 
colleagues [3].  
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Members of the genus Burkholderia inhabit various ecological niches including the 
plant rhizosphere, soil, invertebrates and the human respiratory tract [1, 4, 5]. In 
recent years, several fungal and plant symbionts have also been identified as 
Burkholderia species [6-9]. Some species of the genus Burkholderia are important 
human, animal and plant pathogens. B. pseudomallei is the causative agent of 
melioidosis [10], a potentially fatal human disease and its close relative B. mallei 
causes glanders in animals [11]. Together with Burkholderia thailandensis, they form 
the B. pseudomallei group [3]. The two most important plant pathogens of the genus 
Burkholderia are Burkholderia glumae and Burkholderia gladioli [5]. Both species are 
rice pathogens which have spread around the globe. B. gladioli is able to grow at 
elevated temperatures (30 °C to 35 °C) and is therefore thought to become an 
increasingly serious threat worldwide, as global warming progresses [12]. Aside from 
these for the most part pathogenic species, approximately 40 Burkholderia species 
are known to be mainly plant associated and beneficial, and have therefore been 
referred to as the plant-associated beneficial and environmental (PBE) group [5]. 
Probably the best studied group of Burkholderia is the Burkholderia cepacia complex, 
which is described below in more detail. 
 
1.1.1 The Burkholderia cepacia complex (Bcc) 
The Burkholderia cepacia complex (Bcc) is a group of 20 closely related species [13], 
which are important opportunistic human pathogens but also promising biocontrol 
agents and have great potential for the biodegradation of various pollutants [14]. In 
terms of pathogenicity, several members of the Bcc are closely associated with 
infections in cystic fibrosis patients [15-17] and two prominent members of the Bcc, 
B. cepacia and Burkholderia multivorans, are  known for their ability to cause a fatal 
pneumonia referred to as “cepacia syndrome” [18, 19]. One of the most important 
regulatory systems of the Bcc members is the quorum sensing (QS) system, which 
regulates virulence factor expression, biofilm formation and secondary metabolite 
production [20-23].  
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1.2 Quorum sensing 
Bacteria are unicellular organisms, but they constantly interact with their 
environments, including other bacterial cells in their vicinity. Gram-positive as well as 
Gram-negative bacteria have evolved cell-cell communication systems to coordinate 
their behavior in a cell-density dependent manner, a mechanism called quorum 
sensing (QS). Bacteria capable of QS produce signaling molecules which accumulate 
in the environment as a function of the bacterial population density. When a certain 
threshold is reached, the so called “quorum”, the signaling molecules bind to specific 
receptors, which in turn activate or repress target gene expression [24]. 
Gram-positive bacteria mainly employ circular peptides as signaling molecules, also 
referred to as autoinducing peptides (AIPs) [25, 26]. Various metabolic pathways, 
transporters and most notably secreted virulence factors are regulated by such QS 
systems [25, 26]. Gram-negative bacteria, like Burkholderia sp. use Lux-type QS 
systems, with acyl-homoserine lactones (AHLs) as signaling molecules [27-29].  
QS was first observed in the squid symbiont Vibrio fischeri, a marine bacterium that 
inhabits the light organs of squids and controls bioluminescence by means of QS 
[30]. More than a decade later, Eberhard and colleagues identified the signaling 
molecule which was responsible for the induction of luminescence of V. fischeri as N-
(3-oxohexanoyl)homoserine lactone (3-oxo-C6-HSL) [31]. The term quorum sensing 
to describe bacterial cell-cell communication was coined in 1994 by Fuqua and 
colleagues, although at that time, it was only used for AHL-dependent QS systems 
[32]. 
 
1.2.1 Acyl-homoserine lactone quorum sensing 
Among the different QS signaling molecules, AHLs are at present the most 
thoroughly investigated and have been shown to regulate a spectrum of bacterial 
processes, including biofilm formation, virulence, bioluminescence, motility, 
conjugation and symbiosis [28, 33-35]. A typical AHL-based QS system consists of 
an AHL synthase (LuxI) and a cytoplasmic receptor/transcription factor (LuxR) that 
can bind the AHL signaling molecule [36-39]. AHLs are synthesized by LuxI from 
Chapter I: Introduction 
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acyl-acyl carrier proteins (acyl-ACP) and S-adenosyl methionine (SAM) [28, 40]. 
Transcription of LuxI is often positively regulated by LuxR, creating a positive 
feedback loop resulting in increased AHL production [35].  
All members of the Bcc have at least one QS system, the CepIR system [41-43]. The 
main product of the LuxI homologue CepI is N-octanoyl-homoserine lactone (C8-
HSL) while N-hexanoyl-homoserine lactone (C6-HSL) is produced in lower amounts 
[43, 44]. Besides the CepIR QS system, several Bcc members also harbor additional 
QS systems, like the CciIR system found in B. cenocepacia ET12 lineage strains 
[22].  
 
1.2.2 LuxR-solos 
LuxR-type receptors that lack a cognate LuxI protein are present in many 
proteobacteria, and have been termed LuxR solos or orphans [45-48]. These LuxR 
solos can either be present in bacteria that also have a distinct LuxI/LuxR pair, or in 
bacteria that do not have a LuxI-type protein encoded in their genome [45, 47]. So 
far, LuxR solos have been shown to respond to either 1) exogenously produced 
AHLs ,for example SdiA, which has lost its cognate LuxI protein in several bacteria, 
but still responds to AHLs [49], 2) endogenously produced AHLs from a LuxI homolog 
produced by the same bacterial cell, as seen for the P. aeruginosa LuxR solo QscR 
[50] or 3) signaling molecules other than AHLs. In the latter case, the normally very 
well conserved AHL binding box shows clear deviation from the consensus sequence 
[51]. The most recent examples of LuxR solos interacting with non-AHL molecules 
are LuxR solos from plant-associated bacteria which specifically respond to yet 
unidentified plant-derived molecules [51], and PluR and PauR from Photorhabdus sp. 
which respond to α-pyrones and dialkylresorcinols, respectively [52, 53]and. As PluR 
and PauR were shown to respond to endogenously produced signals other than 
AHLs, the term LuxR solo or orphan might not be suitable for these regulators. All B. 
Cenocepacia strains encode one LuxR solo, designated CepR2, which showed 
negative autoregulation, as well as negative regulation by the CciIR QS system in B. 
cenocepacia strain K56-2 [54]. Furthermore, CepR2 regulates the expression of a 
subset of known QS regulated genes, including a zinc-dependent metalloprotease, 
the biosynthesis genes of the siderophore pyochelin and an uncharacterized NRPS-
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like gene cluster adjacent to cepR2 [54, 55]. Although the AHL binding domain of 
CepR2 shows  very good conservation of the known consensus sequence, Malott 
and colleagues showed that CepR2 is not able to bind AHLs [54], while the study of 
Ryan and Winans showed binding of AHLs by CepR2 [55].  
 
1.2.3 Fatty acid based quorum sensing 
Besides the AHL QS system, several Gram-negative bacteria use QS systems 
employing fatty acid based signaling molecules. This was first reported for the plant 
pathogen Xanthomonas campestris pv campestris, which uses cis-11-methyl-2-
dodecenoic acid (diffusible signal factor; DSF) as a quorum sensing molecule [56, 
57]. A similar QS system was recently shown to exist in B. cenocepacia and the QS 
molecule, cis-2-dodecenoic acid was subsequently termed Burkohlderia diffusible 
signal factor (BDSF) [58]. BDSF accumulates in a cell density-dependent matter but 
unlike in AHL QS, BDSF QS does not involve a positive-feedback loop [59]. BDSF 
has been shown to regulate several important bacterial processes, including motility, 
EPS and protease production, biofilm formation and virulence [60-62]. The AHL- and 
BDSF QS systems control specific and overlapping sets of genes in B. Cenocepacia 
[63]. 
 
1.2.4 Quinolone based quorum sensing 
Several Pseudomonas strains, and also some Burkholderia strains, have a quorum 
sensing system which uses alkyl quinolones (AQs) as signaling molecules [64]. The 
primary signaling molecule of the AQ quorum sensing system is 2-heptyl-3-hydroxy-
4-quinolone, also known as Pseudomonas quinolone signal (PQS), which regulates 
its own biosynthesis as well as several virulence factors such as elastase, 
rhamnolipids and pyocyanin [65-68]. In addition to PQS, its immediate biosynthetic 
precursor 2-heptyl-4-quinolone (HHQ) has been shown to act as a signal molecule. 
HHQ also modulates interspecies and interkingdom behavior and was shown to 
repress biofilm formation in Bacillus subtilis and Candida albicans and exhibited 
bacteriostatic activities against Gram-negative bacteria [69]. The biosynthesis of 
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HHQ is dependent on the pqsABCDE operon, whereas the biosynthesis of PQS from 
its precursor HHQ is dependent on the quorum sensing regulated FAD-
monooxygenase PqsH [65, 70]. PQS production is enhanced under iron limiting 
conditions and was shown to chelate iron, leading to higher siderophore production. 
PQS is thought to associate with the bacterial cell membrane and function as an iron 
trap, which can transfer ferric iron to either pyochelin or pyoverdin [71-74].  
 
 
1.3 Microbe-derived secondary metabolites 
Microbe-derived secondary metabolites are the basis for most drugs currently used in 
clinics, including antibiotics [75]. The success story of antibiotics started with the 
discovery of penicillin from the fungus Penicillium notatum by Alexander Fleming in 
1929 [76]. The subsequent realization that this antibiotic could be used to battle 
multiple microbial infections during the 1940s resulted in the so called “golden age of 
antibiotics “, which lasted for two decades [77].  Nevertheless, it soon  became clear 
that bacteria were able to evolve resistance against antibiotics [78]. While this is an 
inevitable evolutionary mechanism, the misuse and widespread introduction of 
antibiotics has certainly accelerated the development and spread of resistance 
among microbes [77]. Antibiotic resistance normally emerges within several months 
to years [79]. For example, the first penicillin resistant bacteria arose in clinics only 
two years of the introduction of penicillin on the market [78].  
 
1.3.1 Secondary metabolite biosynthesis in the genus Burkholderia 
Burkholderia sp. have proven to be a rich source of natural products with important 
and interesting biological activities, ranging from antibacterial and antifungal 
compounds, to herbicidal and insecticidal agents and metal chelators [3, 80]. The 
analysis of 15 genomes from strains representing the diversity of the genus 
Burkholderia showed that Burkholderia species dedicate up to 14% of their genome, 
equating to 22 gene clusters, to the biosynthesis of secondary metabolites [3]. This 
makes Burkholderia a valuable genus for the discovery of novel antibiotics, with great 
potential for biotechnological applications. Nevertheless, safety concerns regarding 
Chapter I: Introduction 
8 
 
the virulence of many Burkholderia species have hampered the development of 
Burkholderia as a biocontrol agent and its biotechnological exploitation [2, 3]. 
 
1.3.1.1 Secondary metabolite biosynthesis in non-Bcc members 
One of the most prolific non-Bcc members in terms of secondary metabolite 
biosynthesis is Burkholderia thailandensis, a non-pathogenic member of the 
Burkholderia pseudomallei group. This bacterial species is known to synthesize a 
range of bioactive secondary metabolites. Capistruin for example is a ribosomally 
synthesized lasso peptide which exhibits antibacterial activity against Burkholderia 
and Pseudomonas strains [81]. A series of polar compounds (bactobolin A – D) 
derived from an NRPS/PKS hybrid gene cluster [82], which has antibacterial activity 
against several Gram-positive bacteria, has also been isolated from B. thailandensis 
[83]. A molecule representing a third class of secondary metabolites synthesized by 
B. thailandensis is the polyketide thailandamide A, which has cytotoxic and 
anticancer activities [84]. In addition, B. Thailandensis and B. pseudomallei produce 
several benzoquinones with activity against Bacillus subtilis and Saccharomyces 
cerevisae and the ability to inhibit eukaryotic phosphodiesterase [85]. Another natural 
product derived from a cryptic NRPS-PKS hybrid gene cluster is produced by several 
members of the B. pseudomallei group, and was described in 2012 by two 
independent research groups. This molecule was named malleilactone by Biggins 
and colleagues [85] and burkholderic acid by Franke and colleagues [86]. It 
possesses iron chelating properties and was found to be toxic in several non-
mammalian model systems [85]. 
In addition to members of the B. pseudomallei group, several plant-associated 
Burkholderia species have been shown to produce secondary metabolites. The plant 
pathogens Burkholderia glumae and Burkholderia gladioli produce the phytotoxin 
toxoflavin, a yellow pigment which causes rice seedling rot and grain rot [87, 88]. 
Burkholderia gladioli pv. cocovenenans produces the polyketide bongkrekic acid [89] 
as well as an antifungal polyketide from the enacyloxin family [90]. 
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1.3.1.2 Secondary metabolites from symbiotic Burkholderia species 
Bacterial symbionts have emerged as a rich source of secondary metabolites and it 
has become evident that many metabolites originally associated with a eukaryotic 
host are in fact derived from bacterial symbionts.  
The endofungal symbiont Burkholderia rhizoxinica, for example, produces two toxins, 
the macrocylic polyketide rhizoxin [6, 91] and the cyclopeptide rhizonin [92], both of 
which were originally thought to be produced by the fungal host. 
A recent example of a natural product derived from a symbiotic Burkholderia species 
is kirkamide, a metabolite of the C7N aminocyclitol family [93]. Kirkamide was isolated 
from leaves of the plant Psychotria kirkii and was found to be toxic to aquatic 
arthropods and insects. Kirkamide is thought to be encoded by a set of genes in the 
obligate leaf symbiont Candidatus Burkholderia kirkii, which show high similarity to 
biosynthetic genes encoding other aminocyclitol compounds [8].  
Another obligate leaf nodule symbiont, Candidatus Burkholderia crenata, synthesizes 
a cyclic depsipeptide showing biomedical properties, similar to those associated with 
its plant host, Ardisia crenata [9].  
 
1.3.1.3 Secondary metabolite biosynthesis in members of the Bcc 
Members of the Bcc are a rich source of antifungal metabolites but have also been 
shown to produce a wealth of other secondary metabolites with different properties, 
such as siderophores and molecules with antibacterial activities against multi drug 
resistant strains [3, 80].  
 
1.3.1.3.1 Pyrrolnitrin 
One of the best studied antifungal compounds from members of the Bcc is 
pyrrolnitrin, also known as 3-chloro-4-(2`-nitro-3`-chlorophenyl)-pyrrole. Pyrrolnitrinis 
derived from tryptophan by the enzymatic activity of the prnABCD operon [94-96] and 
was shown to be produced by Burkholderia lata [23]. Although its biosynthetic gene 
cluster is also found in other Bcc members, including Burkholderia ambifaria and 
Burkholderia pyrrocinia, members of the B. pseudomallei group and several 
Pseudomonas and Serratia species. It is an important antimicrobial compound which 
shows activity against several Gram-positive bacteria and Candida albicans [97] as 
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well as phytopathogenic fungi, including the potato dry rot fungus Fusarium 
sambucinum and Rhizoctonia solani [23, 98], a soil-borne fungal pathogen that 
causes several different plant disease, among them tobacco leaf spot and root rot 
[99]. 
 
1.3.1.3.2 Xylocandins 
Xylocandins [100] are a group of NRPS-derived cyclic lipopetides produced by 
different Bcc members. Cepacidine A is synthesized by B. Pyrrocinia [100] and B. 
cepacia AF2001 and was found to exhibit antifungal activity [101]. In addition, 
cepacidine A was shown to have immunosuppressive activity [102]. Burkholdines 
1097 and 1229 were isolated from Burkholderia ambifaria. Both molecules are cyclic 
octapeptides comprised of nonproteinogenic amino acids and were shown to be 
potent antifungal agents [103]. Additional members of the xylocandin complex are 
occidiofungins, antifungal glycopeptides which were isolated from B. Pyrrocinia [104] 
and Burkholderia contaminans cultures and have potent antifungal activity against 
several important pathogenic fungi [105, 106], including Aspergillus fumigatus and 
Aspergillus niger, which are common causes of invasive pulmonary aspergillosis 
[107]. Burkholderia vietnamensis has a biosynthetic gene cluster homologous to the 
occidiofungin/burkholdine gene clusters. Mutation of genes within this NRPS cluster 
resulted in reduced hemolytic activity and reduced killing of the wax moth larva 
Galleria mellonella [108]. 
 
1.3.1.3.3 AFC-BC11 
Burkholderia pyrrocinia, formerly known as Burkholderia cepacia BC11, synthesizes 
a lipopeptide with potent antifungal activity against Rhizoctonia solani. Although its 
structure has not yet been fully elucidated, AFC-BC11 reportedly consists of four 
amino acids, an aromatic component and a fatty acyl substituent. Furthermore, the 
lipopeptide was mainly associated with the membrane of B. pyrrocinia and only small 
amounts could be found in the culture supernatant [109]. The biosynthesis of AFC-
BC11 has not been investigated, but the production of the molecule is associated 
with the afc cluster, which is located on megaplasmid pC3 of B. pyrrocinia and B. 
cenocepacia [109, 110]. The afc cluster was shown to be regulated by ShvR, a LysR-
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type regulator encoded adjacent to the afc genes [111]. Furthermore, mutations of 
two genes from the afc cluster, afcE and afcF, resulted in the loss of antifungal 
activity in B. cenocepacia K56-2 [112]. 
 
1.3.1.4 Siderophores 
Iron is one of the most important trace elements necessary for bacterial survival. 
Although it is one of the most abundant elements on Earth, iron is not readily 
available to bacteria, as it is rapidly oxidised from Fe2+ to insoluble Fe3+ in the 
presence of oxygen and at neutral pH. One of the most important bacterial strategies 
to solubilize iron is the production of siderophores, low molecular weight molecules 
which chelate iron outside the cell and are subsequently taken up via specific 
transporters [113, 114]. Members of the genus Burkholderia are able to produce and 
secrete a range of structurally different siderophores, mainly from the hydroxamate, 
catecholate and phenolate classes of molecules [115, 116].  
 
1.3.1.4.1 Pyochelin 
The phenolate siderophorepyochelin is synthesized by B. cepacia and B. 
cenocepacia and occurs in two stereoisomeric forms, pyochelin I and pyochelin II 
[117-119]. Two pyochelin molecules are necessary to bind one ferric ion [120] but the 
siderophore was also shown to bind other metals including zinc, copper, cobalt, 
vanadium and molybdenum [121-123]. Pyochelin is induced in the presence of 
aluminum under low iron and iron-replete conditions [124]. Pyochelin is synthesized 
from two L-cysteine residues and one salicylate residue by two NRPS enzymes, 
PchE and PchF [117, 125]. Although the pyochelin biosynthesis cluster is present in 
most B. cepacia and B. cenocepacia strains, about 50% of clinical Bcc isolates 
testedwere found either to produce no pyochelin, or negligible amounts [126, 127], 
which might be explained by the fact that the NRPS gene pchF has a frameshift 
mutation in several strains, including B. cenocepacia J2315. 
 
1.3.1.4.2 Ornibactin 
The linear tetrapeptide ornibactin possesses two hydroxamate and α-hydroxy 
carboxylate metal chelation groups and is the most prevalent siderophore among 
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Burkholderia species [115, 127], being produced by Bcc species including B. 
cepacia, B. cenocepacia, B. ambifaria and B. vietnamiensis [127-129]. Ornibactin 
biosynthesis is directed by the orb gene cluster, with orbI and orbJ coding for the two 
NRPS enzymes responsible for the biosynthesis of the peptide chain [130]. Mutations 
in the ornibactin biosynthesis genes and receptor in B. cenocepacia K56-2 resulted in 
attenuated virulence in the two invertebrate model organisms Caenorhabditis 
elegans and Galleria mellonella [131]. Ornibactin biosynthesis is upregulated under 
low iron conditions and is part of the Fur regulon.  Fur regulates transcription of the 
OrbS sigma factor, which directs transcription of the ornibactin biosynthetic and 
transport genes [130]. Recently, it was shown that ornibactin expression is increased 
in the presence of zinc, copper and aluminum. In addition, ornibactin allowed 
Burkholderia to grow in the presence of aluminum, zinc, lead and copper, while 
growth of the respective ornibactin mutant strains was inhibited by these metals.  
This indicates that ornibactin can protect the cells from the toxic effects of these 
metals [124]. 
 
1.3.1.4.3 Additional siderophores 
Members of the B. pseudomallei group synthesize the siderophore malleobactin 
[132], which is structurally very similar to ornibactin. The two molecules differ in the 
presence of a 2-amino-5-nitropentanoic acid in malleobactin, which replaces the N-
hydroxy-N-acylornithine moiety present in ornibactin [133]. Furthermore, a 
siderophore was reported to be produced by Burkholderia xenovorans, which was 
proposed to be structurally related to malleobactin, but a complete structural 
elucidation is still pending [134]. 
The cyclic hydroxamate siderophore cepabactin was shown to be produced under 
iron-limited conditions by B. cepacia [135] and the catecholate siderophore 
cepaciachelin is produced by Burkholderia ambifaria isolated from the plant 
rhizosphere [136].   
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1.4 Regulation of secondary metabolite biosynthesis  
It has become clear that in the genus Burkholderia, many secondary metabolites are 
regulated by quorum sensing as well as solo LuxR-type regulators, which can either 
be responsive to AHLs or not. 
 
1.4.1 Regulation by quorum sensing 
In the B. pseudomallei group, bactobolins, polar antibiotics derived from B. 
thailandiensis E264, were shown to be regulated by the BtaR2/BtaI2 quorum sensing 
system [83]. 
One of the most prominent secondary metabolites demonstrated to be quorum 
sensing regulated is pyrrolnitrin, which has been described above. Schmidt and 
colleagues showed that pyrrolnitrin production is dependent on the CepIR QS system 
in B. lata strain 383 and enzymatic inactivation of QS in B. ambifaria LMG19467 and 
B. pyrrocinia LMG21823 abolished or greatly reduced pyrrolnitrin production in these 
two strains [23].  
B. ambifaria produces the polyketide metabolites enacyloxin IIa and its isomer cis-
enacyloxin IIA which are highly active against the multi-drug resistant Gram-negative 
bacteria Burkholderia multivorans, Burkholderia dolosa and Acinetobacter baumannii 
[137]. Enacyloxin production was highest when the bacteria were grown with glycerol 
as sole carbon source and after they had reached stationary phase. Furthermore, 
enacyloxin production was dependent on the AHL synthase CepI as well as the 
presence of a solo LuxR-type regulator which is part of the enacyloxin biosynthesis 
cluster [137]. 
Occidiofungins, antifungal glycopeptides from several Bcc members, were shown to 
be regulated by two solo LuxR-type regulators, designated AmbR1 and AmbR2, 
which are encoded in close vicinity to the occidiofungin biosynthesis genes [138, 
139]. Furthermore, a solo LuxR-type regulator which is part of an NRPS gene cluster 
in B. vietnamiensis DBO1 was essential for hemolytic activity and G. mellonella 
mortality; which was also shown for several mutants in the NRPS gene cluster [108]. 
A transposon mutagenesis study in B. ambifaria by Chapalain and colleagues 
confirmed the regulation of pyrrolnitrin by QS and also showed reduced expression of 
Chapter I: Introduction 
14 
 
genes from the enacyloxin and occidiofungin clusters in a cepI mutant background 
[140].  
The two siderophores pyochelin and ornibactin are also quorum sensing regulated in 
B. cenocepacia. While ornibactin was demonstrated to be negatively regulated by the 
CepIR QS system [131, 141], pyochelin is not directly regulated by CepIR but is 
positively regulated by the solo LuxR-type regulator CepR2 [54].  
 
 
1.5 The biosynthesis of secondary metabolites 
Most antibiotics used to date derive from two distinct molecule classes, polyketides 
(PK) and non-ribosomal peptides (NRP) [75, 142-146]. In addition to their antibiotic 
activities, molecules of these classes can also possess potent antitumor or antiviral 
activity while some are used as immunosuppressives or can act as toxins. PKS and 
NRP are synthesized by multi domain enzymes known as non-ribosomal peptide 
synthetases (NRPS), with each domain serving a specific function, e.g. substrate 
recognition or chain elongation in the biosynthetic assembly line [147-152].   
 
1.5.1 Non-ribosomal peptides (NRP) 
NRPS-derived secondary metabolites have very high structural diversity. This is 
owed to the fact that not only the 20 proteinogenic amino acids can be incorporated 
into NRPS molecules, but also D-amino acids, carboxylic acids and α-hydroxy acids. 
Besides that, NRPS-derived molecules can also undergo extensive modifications, 
including methylation, acylation, glycosylation and ring formation. Finally, the release 
of the assembled molecule from the NRPS enzyme can yield a linear, cyclic or 
macrocyclic peptide. While the majority of known NRPS-derived molecules are 
assembled in a linear fashion, meaning that the single building blocks are 
incorporated in the growing peptide chain in the same order as the modules present 
in the assembly line, several NRPS-derived molecules have been identified which are 
synthesized in an iterative fashion [153]. Linear NRPS assembly lines start with an 
initiation module, followed by one or several elongation modules and end with a 
termination module. A detailed description of these three module types is given 
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below. Modules of iterative NRPS assembly lines are used more than once, which 
results in the incorporation of the same subunit into the final molecule multiple times. 
Enterobactin [154] and gramicidin S [155], for example, are synthesized by iterative 
NRPS assembly lines.  
 
1.5.1.1 NRPS modules 
Three different types of modules can be distinguished for NRPS enzymes. The 
NRPS assembly line starts with an initiation module, which is followed by one or 
more elongation modules and ends with the termination module. The initiation 
module normally starts with an adenylation (A) domain, followed by a thiolation (T) 
domain, which is also called peptidyl carrier protein (PCP) domain. In certain cases, 
starter condensation (starter C) domain can preceed the first domain of the initiation 
module. Elongation modules consist of three domains, the condensation (C) domain, 
an A domain and a T domain [147, 156]. The last module in the NRPS assembly line 
is the termination module which either ends with a thioesterase (TE) or a reductase 
(R) domain and is responsible for the release of the assembled molecule [157].  The 
molecular function of the different NRPS modules are discussed below and an 
overview of an NRPS assembly line is shown in Figure 2.  
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Figure 2 : Model of an NRPS assembly line. The amino acid is activated by the adenylation 
(A) domain and tethered to the thiolation (T) domain. The condensation (C) domain catalyses 
the peptide bond formation of amino acids of tethered to two adjacent T domains. The 
assembled peptide is release by the thioesterase (TE) domain via hydrolysis or cyclisaton. 
Modified from Winn and colleagues [158]. 
 
1.5.1.1.1 Initiation of peptide biosynthesis 
Canonical NRPS enzymes start with an A domain at their N-terminus, which is 
responsible for initiating peptide formation. In special cases, NRPS enzymes start 
with a starter C domain. These domains connect the amino acid of the first A domain 
with a β-hydroxy-carboxylic acid [159]. The lipopeptides surfactin [160], lichenysin 
[161], fengycin [162] and arthrofactin [163] all derive from NRPS enzymes that have 
a starter C as the very first domain in their assembly line.  
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1.5.1.1.2 Peptide elongation cycle 
The A domain of each module is responsible for the recognition and activation of the 
substrate amino acid. The amino acid is activated in an ATP-dependent adenylation 
step and the resulting aminoacyl adenylate intermediate is then tethered to the free 
thiol group of the 4`-phosphopantetheine (ppant) arm present on the T domain. The 
ppant arm is located on a conserved serine residue and derived from coenzyme A 
[164-167]. Subsequently, the C domain is responsible for the formation of a peptide 
bond between the T domain-bound amino acids of two adjacent modules [168]. C 
domains contain a conserved motif in their active site, with the consensus sequence 
HHxxxDG. The second histidine in the motif has been shown to be essential for the 
catalytic function of the C domain [169]. In addition to the already described starter C 
domain, three other subtypes of C domains exist. The most common one is the LCL 
domain, which catalyses peptide bond formation between two L-amino acids. DCL 
domains catalyse peptide bond formation between a D- and an L-amino acid. They 
are normally located immediately downstream of an epimerase (E) domain and are 
enantiospecific for D-amino acids from the donor site and L-amino acids from the 
acceptor site [170, 171].  The third C domain subtype is the dual E/C domain, which 
catalyses the epimerization of one amino acid and subsequent peptide bond 
formation with the second amino acid [172].  
 
1.5.1.1.3 Peptide release 
The growing peptide chain is covalently tethered to the NRPS enzyme during the 
whole elongation process. Only when the peptide reaches the termination module, is 
it  released from the NRPS. In most cases, the peptide is released via the action of a 
TE domain.  This is achieved by transferring the peptide to the hydroxyl of a serine 
residue located in the active site of the TE domain, and a peptidyl-acyl-O-serine 
intermediate is formed. The intermediate is then attacked by either an external 
nucleophile and the linear peptide is released by hydrolysis. Alternatively, an internal 
nucleophile attack from the peptide intermediate itself can lead to  release by 
macrocyclization [157]. Linear peptide release by hydrolysis was demonstrated for 
yersiniabactin and vancomycin [173, 174], while release by macrocyclization was 
shown for daptomycin and erythromycin [175, 176].  
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In addition to TE domain catalysed peptide release, several NRPS systems have a R 
domain in their termination module. The peptide can be released from the NRPs 
either by a two-electron or a four-electron reduction. Release by a two-electron 
reduction was first described for the Lys2 protein from the lysine biosynthetic 
pathway [177]. In gramicidin A biosynthesis, the R domain also catalyses a two-
electron reduction, but the aldehyde intermediate is then further reduced to an 
ethanolamine by an NADPH-dependent aldoreductase [178, 179].   
Release by a four-electron reduction has been demonstrated for the biosynthesis of 
myxochelin A and B [180] as well as lyngbyatoxin [181]. During the release of the 
NRPS-bound myxochelin intermediate, the aminoacyl-S-T thioester is first reduced to 
an aldehyde in a two-electron reduction step, followed by a second two-electron 
reduction step to an alcohol, which yields myxochelin A. Interestingly, the second 
two-electron reduction step can be prevented by competitive transamination of the 
aldehyde to yield myxochelin B [180].  
 
1.5.1.2 Tailoring reactions 
The vast diversity of NRPS-derived secondary metabolites is partially owed to the 
introduction of structural diversity by tailoring reactions. Such tailoring reactions can 
be accomplished by enzymatic domains directly encoded by the NRPS enzyme or by 
separately encoded enzymes [158, 182, 183]. Most NRPS-derived molecules are 
modified by tailoring enzymes after release of the assembled peptide (post-assembly 
tailoring), but there are reports on a growing number of secondary metabolites which 
undergo structural modification while the intermediates are still bound to the NRPS 
enzyme. These tailoring reactions are referred to as on-line tailoring [182]. 
 
1.5.1.2.1 Epimerization reactions 
A prominent tailoring reaction is the epimerization of L-amino acids to D-amino acids 
during the biosynthesis of the growing peptide chain. As discussed above, these 
reactions are carried out by E domains or by dual E/C domains as well as racemases 
[183]. Rather than a full conversion of L- to D-amino acids, E domains produce a 
racemic mix of D- and L- amino acids and the incorporation of the D-amino acid in 
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the growing peptide chain is dependent on the enantio specificity of the following DCL 
domain, as seen in gramicidin S synthesis [184]. In contrast, in cyclosporin and HC-
toxin biosynthesis, D-alanine, which is the first residue in both molecules, is provided 
by an alanine racemase [185, 186].  
 
1.5.1.2.2 Glycosylation reactions 
Glycosylations are an important modification of NRPS derived molecules, such as the 
clinically important glycopeptide antibiotics vancomycin, teicoplanin and 
chloroermomycin [187]. The glycosylation reactions are post-assembly tailoring steps 
which are carried out by glycosyltransferases encoded in the respective biosynthesis 
clusters [188-192]. Frequently, the sugars added to the NRPS backbone are not D-
isomers, but rather nucleoside diphosphoesters of deoxy- and aminodeoxyhexoses 
[193, 194]. The enzymes which convert the abundant metabolites UPD-glucose and 
TDP-glucose to the necessary NDP-hexoses are often also encoded within the 
NRPS biosynthesis clusters [195].  
 
1.5.1.2.3 Oxidative tailoring 
One of the best studied and most important examples of oxidative tailoring is the 
production of β-lactam antibiotics. After release from the NRPS assembly line, the 
biosynthesis intermediate aminoadipoyl-cysteinyl-valine (ACV) is first oxidized by the 
FeII-α-ketoglutarate dependent oxygenase isopenicillin N synthase to yield 
isopenicillin N. After epimerization to penicillin N, a second oxygenase 
deacetoxycephalosporin C synthase oxidizes the molecule to 
deacetoxycephalosporin C [196-198]. Besides post-assembly oxidation, vancomycin 
and teicoplanin also undergo on-line oxidative tailoring by several hemeproteins from 
thecytochrome P450 family [174]. These reactions take place while the peptide is still 
bound to the last T domain of the assembly line. The conversion from the acyclic 
heptapeptide to the cup-shaped final structure of vancomycin and teicoplanin is 
thought to trigger the TE domain-catalysed release of molecules from the assembly 
line [199-201].  
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1.5.1.2.4 Methylation reactions 
N-methylation of NRPS molecules is carried out by N-methyltransferases, which are 
encoded between the A and the T domain. Accordingly, methylation is carried out 
while the amino acid is incorporated into the growing peptide chain [169]. The methyl 
group is derived from S-adenosylmethionine and in most cases it is transferred to the 
amino group of the T domain-tethered amino acid [202]. In the case of enniatin and 
the cyclooctadepsipeptide PF1022A, N-methylation takes place on the amino acid 
monomer before incorporation into the peptide chain [203, 204]. 
C-methylation is found in the PKS/NRPS hybrid molecule yersiniabactin, where the 
first methylation domain (MT1) acts on the PKS part of the molecule and the second 
methylation domain (MT2) acts on the NRPS part of the molecule [205].  
O-methylation has been reported for the NRPS-derived molecule saframycin Mx1. A 
standalone O-methyltransferase encoded in the saframycin biosynthetic cluster is 
proposed to carry out the methylation reaction. Nevertheless, there are three distinct 
methylations found in the saframycin Mx1 structure and it is not known which of these 
is carried out by the o-methyltransferase [206].  
 
1.5.1.2.5 Hydroxylation reactions 
Important antibiotics like vancomycin, bleomycin and novobiocin contain β-hydroxy 
amino acids. It was shown that during novobiocin biosynthesis, the cytochrome P450 
monooxygenase NovI introduces one atom from O2 at the C3 position of a T domain 
tethered tyrosine, which yields T domain tethered β-hydroxyamino acid (3R)-3-OH-
tyrosine [207]. 
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Aims of the thesis 
Antifungal activity of B. cenocepacia was thought to depend on the presence of the 
afc gene cluster located on megaplasmid pC3. This work was initiated by the 
observation that deletion of megaplasmid pC3 resulted in complete loss of antifungal 
activity in B. cenocepacia K56-2 while strain H111 still showed antifungal activity. 
This indicated that another antifungal compound is encoded by one of the two 
chromosomes in B. cenocepacia H111.  
The aim of this thesis was to identify the genetic locus responsible for the antifungal 
activity of Burkholderia cenocepacia H111 and to entangle the regulation of 
antifungal activity. Furthermore, this thesis aimed to elucidate the chemical nature of 
the antifungal metabolite(s) produced by B. cenocepacia H111. In the course of this 
study it became apparent, that the same genetic locus which is responsible for the 
biosynthesis of the antifungal metabolite, also produces a novel signalling molecule. 
Thefore we also persued to chemically characterize this novel signalling molecule 
and determine its regulon. 
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Chapter II: Results 
 
2 Results I: Microbial Antagonism 
 
2.1 Identification of genetic clusters involved in antifungal 
activity 
Many antifungal compounds are either polyketides (PK), non-ribosomal peptides 
(NRP) or hybrids thereof. Genome-wide identification of secondary metabolite 
biosynthesis gene clusters with the antiSMASH 3.0 software [208] identified a total of 
15 secondary metabolite clusters, of which three are non-ribosomal peptide 
synthetase (NRPS) clusters and one is a type 1 polyketide synthase (PKS) cluster 
(Table 1). The predicted PKS cluster is part of the capsular polysaccharide I locus, 
while the identified NRPS like clusters are the well characterized ornibactin and 
pyochelin biosynthesis gene clusters and a so far uncharacterized NRPS-like gene 
cluster (Table 1).  
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Table 1: Secondary metabolite clusters of B. cenocepacia H111 predicted with the 
AntiSMASH 3.0 software 
 
It was previously established that enzymatic inactivation of the AHL-dependent QS 
system with the Bacillus sp. derived AiiA lactonase reduced antifungal activity in 
different Burkholderia strains, among them B. cenocepacia H111 [23]. This suggests 
that antifungal activity of B. cenocepacia H111 is under QS control. In addition, 
antifungal activity of B. cenocepacia K56-2 is dependent on the afc gene cluster 
[112], which is located on megaplasmid pC3 in several B. cenocepacia strains [110]. 
Interestingly, when B. cenocepacia H111 is cured of megaplasmid pC3, antifungal 
activity is reduced, but not entirely lost [110]. This indicates that pC3 might have a 
regulatory effect on antifungal activity of B. cenocepacia H111, rather than directly 
encode the antifungal determinant. To explore this possibility and identify candidate 
NRPS or PKS clusters for the biosynthesis of the unknown antifungal agent produced 
by strain H111, the published transcriptomes of the QS mutant B. cenocepacia H111 
ΔcepR and a ΔpC3 derivative strain were compared with the transcriptomes of the 
H111 parental strain [110, 209]. The uncharacterized NRPS-like gene cluster 
Replicon Type 
Location  
(nt start – stop) 
Function 
Chromosome 1 T1PKS 682853 – 730463 
Capsular polysaccharide 
locus 
Chromosome 1 NRPS 1712441 – 1767140 Ornibaction biosyntehsis 
Chromosome 1 Terpen 2083072 – 2103905 unknown 
Chromosome 1 Arylpolyene 3045402 – 3086625 unknown 
Chromosome 2 Bacteriocin 28172 – 41229 unknown 
Chromosome 2 NRPS 203774 – 251199 
Uncharacterized NRPS-
like 
Chromosome 2 Phosphonate 1215171 – 1256859 unknown 
Chromosome 2 Terpene 1409532 – 1430599 unknown 
Chromosome 2 Homoserinelactone 1959336 – 1979944 unknown 
Chromosome 2 Terpene 2141000 – 2162079 unknown 
Chromosome 2 Terpene 2221517 – 2242587 unknown 
Chromosome 2 NRPS 2384780 – 2437568 Pyochelin biosynthesis 
Chromosome 2 Terpene 3081510 – 3102677 unknown 
pC3 Terpene 188420 – 210300 unknown 
pC3 Bacteriocin 717851 - 728666 unknown 
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(I35_4188 – I35_4195) identified by antiSMASH 3.0 was downregulated in both the 
ΔcepR and the ΔpC3 mutant compared to the wild type strain (Table 2). The gene 
cluster consists of two operons, which are transcribed in opposite directions, one 
comprising five and the other two genes, which were named hamABCDE (H111 
antifungal metabolite, see below) (I35_4191 – 4195) and hamFG (I35_4189 and 
I35_4188) (Figure 3A).  
 
Table 2: Deregulation of the ham genes in the published transcriptomes of a pC3-null mutant 
(ΔpC3)   and a CepR quorum sensing mutant (ΔcepR) compared to the wild type strain (wt). 
Data derived from [110, 209]. 
 
Often the expression and transport of secondary metabolites is governed by 
regulators and transporters encoded within the respective PKS and NRPS gene 
clusters [148]. Located upstream of the hamFG operon are genes encoding the 
AraC-type regulator CepS (I35_4187) and the solo LuxR-type regulator CepR2 
(I35_4186), which were both shown to be involved in the regulation of the ham 
cluster in B. cenocepacia K56-2 [54, 55]. Located immediately downstream of the 
hamAE operon are genes encoding an uncharacterized AraC-type (I35_4197) and a 
LysR-type regulator (I35_4196). In addition, a tripartite multidrug resistance system 
(mdr1-mdr3; I35_4198 – I35_41200) is located near the ham cluster (Figure 3A). 
  
Gene Name ΔpC3 vs wt* ΔcepR vs wt J2315 ortholog 
I35_4188 hamG -5,0 -22,1 bcam0190 
I35_4189 hamF -4,9 -12,8 bcam0191 
I35_4191 hamA -12,0 -46,8 bcam0192 
I35_4192 hamB -12,2 -47,7 bcam0193 
I35_4193 hamC -14,5 -52,2 bcam0194 
I35_4194 hamD -9,3 -34,0 bcam0195 
I35_4195 hamE -10,4 -37,7 bcam0196 
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Figure 3: Genetic 
organization and 
domain predictions 
of the ham cluster 
and surrounding 
genes. A) The ham 
cluster is organized 
into two operons 
and surrounded by 
genes encoding four 
regulators and an 
uncharacterized 
multi-drug 
resistance system. 
Domains typical for 
NRPS-like enzymes 
were found in hamD 
and hamF. B) 
Predictions of 
protein domains and 
enzyme functions 
for all seven ham 
genes. Predictions 
were made with the 
Interproscan online 
tool. C) Amino acid 
alignment of HamC 
with its 
characterized 
homologues AurF 
and PsAAO. Metal 
coordinating 
residues are 
highlighted in dark 
grey, residues of the 
active site pocket 
are highlighted in 
yellow and residues 
from the second 
coordination sphere 
are highlighted in 
green.  
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2.2 Bioinformatic predictions of the ham gene cluster  
The NRPS-like protein HamD encodes for an adenylation (A) domain, a thiolation (T) 
domain and a reductase (R) domain (NRPS/PKS analysis tool) [210] (Figure3A). 
Further analysis of the hamD-encoded A domain predicted phenylalanine (NRPSsp 
online tool) [211] and leucine (NRPSpredictor2 online tool) [212] as the most likely 
amino acid substrates (Table 3). HamF is a free-standing starter C domain 
(InterProScan 5; NaPDoS; Natural Product Domain Seeker) [213] (Figure 3A). In 
contrast to conventional C domains, starter C domains acylate amino acids bound to 
the T domain with a β-hydroxy-carboxylic acid [159]. Thus, the main building blocks 
of the predicted biosynthetic product of the ham cluster are an amino acid and a fatty 
acid. Analysis of the remaining five genes in the ham cluster with the InterProScan 5 
online tool suggested that they are tailoring enzymes (Figure 3B).  
 
Table 3: Substrate specificity of the HamD, PvfC and MgoA A domains 
 
The putative tailoring enzyme HamC, is an arylamine N-oxygenase. Alignments of 
HamC with its characterized homologs from Streptomyces thioluteus (AurF) and 
Pseudomonas syringae pv. phaseolicola (PsAAO) show conservation of the iron-
coordinating ligands and residues for establishing the second coordination sphere 
(Figure 3C), as has been shown previously [214]. The residues responsible for 
substrate specificity are highly conserved between HamC and PsAAO (Figure 3C) 
suggesting a similar substrate range. Both enzymes, AurF and PsAAO, have 
aromatic amine substrates and catalyze the oxidation of the amino group to a nitro 
group [214, 215].  
Enzyme Residues binding pocket* 
Amino acid substrate 
NRPSpredictor2 
Amino acid 
substrate 
NRPSsp 
HamD DALFVGIV Leucine Phenylalanine 
PvfC DALFVGIV Leucine Phenylalanine 
MgoA DSIFMGLV Leucine Phenylalanine 
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An architecture search of the ham cluster with the multi gene blast software showed 
that homologs of the ham cluster are present in most sequenced B. cenocepacia 
strains (Figure 4). Furthermore, the hamABCDE operon is fully conserved in 
Burkholderia glumae PG1, Pseudomonas aeruginosa PA7 and Pseudomonas 
fluorescens strain X. A homologous operon that lacks hamB is also present in various 
Pseudomonas and Pandoraea species (Figure 4). Two of these operons, pvf and 
mgo from Pseudomonas entomophila and Pseudomonas syringae pv. syringae 
UMAF0158, respectively, were previously shown to synthesize an unknown signal 
molecule which regulates virulence and the production of secondary metabolites 
[216, 217]. In this context it was of interest to know if PvfC and MgoA might have the 
same amino acid substrate as HamD. Prediction and comparison of the residues 
present in the A domain substrate binding box of the three proteins with the 
PKS/NRPS analysis software [210] could not identify a possible amino acid 
substrate, but showed full conservation of the residues in the substrate binding box 
between HamD and PvfC, while MgoA differed in four out of eight amino acids (Table 
3). Additional analysis with the NRPSpredictor2 and NRPSsp software predicted 
leucine and phenylalanine as substrates for all three enzymes (Table 3). Based on 
these predictions, the amino acid incorporated into the final biosynthesis product of 
the ham, pvf and mgo cluster is likely to be the same.  
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Figure 4 : Distribution of the ham gene cluster 
in the domain bacteria. Shown are the top 50 
hits derived from a multigene blast of all 
seven ham genes identified in B. cenocepacia 
H111, against the complete bacterial genomic 
database at NCBI. Red = HamA; blue = HamB; 
green = HamC; pink = HamD; yellow = HamE; 
grey = HamF and cyan = HamG. 
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2.3 Antifungal activity is quorum sensing controlled, but not 
dependent on the afc gene cluster 
Antifungal activity of B. cenocepacia H111 is reduced by enzymatic inactivation of the 
quorum sensing signaling cascade [23], but direct proof of the dependency of 
antifungal activity on QS is not available. To unequivocally prove that antifungal 
activity is regulated by QS and that the observed reduction of antifungal activity by 
enzymatic inactivation of the QS system is not due to a pleiotropic effect of lactonase 
overexpression, we tested a strain in which the AHL synthase gene cepI, together 
with the QS regulator gene cepR, were deleted, for antifungal activity against 
Fusarium solani and Rhizoctonia solani. In agreement with the QS quenching 
approach, the H111 ΔcepIR mutant showed an approximately 50 % reduction in 
antifungal activity against both fungi (Figure 5).  
 
 
Figure 5: Regulation of antifungal activity by the quorum sensing system. Reduction of 
antifungal activity in a cepIR mutant (H111 ΔcepIR) compared to the wild type strain (H111 
wt) against the fungus A) Fusarium solani and B) Rhizoctonia solani. Area of inhibition refers 
to the difference in plate surface covered with the fungus in the presence and absence of 
bacteria. Results are represented as means ± SD derived from at least 3 independent 
experiments. Representative pictures of the antifungal assays are shown below the 
respective bars.  
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To determine if the reduction of antifungal activity in the pC3-negative derivative of 
strain H111 is due to the loss of the afc cluster, an afcA mutant was tested for 
antifungal activity in dual culture plate assays as well as by fungal spray assay. 
Deletion of afcA did not alter the capability of strain H111 to inhibit the growth of F. 
solani and R. solani (Figure 6A and 6B), while the pC3-negative strain showed 
reduced antifungal activity (Figure 6C) against F. solani, as reported before [110]. 
This is compelling evidence that antifungal activity of B. cenocepacia H111 is not 
dependent on the afc cluster but is probably dependent on the ham cluster.   
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Figure 6: Impact of AfcA on antifungal activity of B. cenocepacia H111. Antifungal activity in 
an afcA mutant (H111 ΔafcA) compared to the wild type strain (H111 wt) against the fungus 
A) Fusarium solani and B) Rhizoctonia solani. Area of inhibition refers to the difference in 
plate surface covered with the fungus in the presence and absence of bacteria. Results are 
represented as means ± SD derived from at least 3 independent experiments. 
Representative pictures of the antifungal assays are shown below the respective bars. C) 
Antifungal activity is reduced in the pC3 negative derivative (H111 ΔpC3) of strain H111, 
compared to the wildtype strain (H111 wt) and the afcA mutant (H111 ΔafcA)..Antifungal 
activity is seen as a zone of fungal growth inhibition around the bacterial colony. 
Representative pictures of antifungal spray assays against the fungus F. solani are shown. 
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2.4 Antifungal activity is inversely regulated by CepR2 in strain 
H111 and K56-2 
In a recent publication, the ham cluster was shown to be regulated by the two 
adjacently encoded regulators CepR2 and CepS in B. cenocepacia K56-2 [55]. In the 
proposed regulation model, the binding sites of CepR2 and CepS are located in the 
intergenic promoter regions of the ham cluster. CepR2 is thought to be a negative 
regulator that upon binding to its operator site blocks binding of the positive regulator 
CepS to the promoter region. To test if CepR2 negatively regulates B. cenocepacia 
antifungal activity, a cepR2 mutant of B. cenocepacia H111 and K56-2 along with 
their respective wildtype strains were tested for antifungal activity against F. solani. 
The B. cenocepacia K56-2 wild-type strain exhibited less antifungal activity against F. 
solani than the B. cenocepacia H111 wild-type strain (Figure 7A). The B. 
cenocepacia H111 cepR2 mutant was devoid of antifungal activity. In contrast, the 
K56-2 cepR2 mutant strain showed increased fungal inhibition, which was 
comparable to that of the H111 wild-type strain (Figure 7A). This observation is in 
agreement with the proposed model of Ryan et al [55], that CepR2 is a negative 
regulator of the ham cluster in K56-2. In stark contrast, a cepR2 mutant in strain 
H111 resulted in complete abbrogation of antifungal activity. To understand if this 
apparent discrepancy could be explained by a difference in the CepR2 structure or 
the CepR2 DNA binding site in the ham promoter region, the amino acid sequences 
of the K56-2 and H111 CepR2 protein were compared. An alignment of the amino 
acid sequences of the two proteins showed that they only differ by a single 
aminoacid. Importantly, the six amino acids responsible for AHL binding are fully 
conserved between the two proteins (Figure 7B). Inspection of the ham promoter 
region, especially of the CepR2 DNA binding site (as proposed in [55]), showed that 
the two CepR2 binding boxes only differ by one nucleotide (Figure 7C). 
 
Chapter II: Results 
33 
 
 
Figure 7: Regulation of antifungal activity by CepR2. A) Antifungal activity of the H111 wild 
type (H111 wt) is absent in  the cepR2 mutant (H111 ΔcepR2). In strain K56-2, antifungal 
activity is lower in the K56-2 wild type (K56-2 wt) strain than in the cepR2 mutant (K56-2 
ΔcepR2) derivative. B) The AHL binding domain of CepR2 is fully conserved between strains 
H111 and K56-2. Amino acid residues involved in AHL binding are highlighted in red. C) 
Nucleotide sequence of the CepR2 binding box of strains K56-2 and H111, according to 
Ryan and colleagues [55]. The difference between the nucleotide sequences of the two 
strains is highlighted in red. 
 
2.5 The ham cluster is essential for antifungal activity of B. 
cenocepacia H111 
After identification of the ham cluster as the possible source of the main antifungal 
compound of B. cenocepacia H111, the importance of the ham cluster for antifungal 
activity against the two fungal pathogens F.solani and R.solani was examined. Non-
polar mutants in hamD and hamF were constructed as described in the material and 
methods section and, together with their respective in trans complemented 
derivatives, tested for activity against F. solani and R. solani. Deletion of hamD 
resulted in a strong decrease in antifungal activity. Deletion of the gene encoding the 
starter condensation domain protein HamF resulted in severely lowered antifungal 
activity against F. solani, but only a slight reduction of antifungal activity was 
observed against R. solani (Figures 8A and 8B). In trans complementation of H111 
ΔhamF and H111 ΔhamD resulted in antifungal activity comparable to the wildtype 
strain against both fungi (Figures 8A and 8B), Therefore both operons of the ham 
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cluster seem to be essential for full antifungal activity and are likely to be involved in 
the biosynthesis of the main antifungal compound produced by strain H111. To 
ascertain the importance of individual ham genes for antifungal activity, non-polar 
mutants of the remaining five ham genes (hamA, hamB, hamC, hamE and hamG) 
were constructed. The wild-type strain and all seven ham mutant strains along with 
their in trans complemented derivatives were tested for antifungal activity against F. 
solani by antifungal spray assay. All seven ham mutants showed a complete loss of 
antifungal activity while the activities of their respective in trans complemented 
derivatives were comparable to that of the wild type (Figure 8C). This proves that the 
ham cluster is essential for antifungal activity and that the two ham operons most 
likely constitute a single biosynthetic unit which synthesizes the major antifungal 
compound of strain H111.  
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Figure 8: Antifungal activity is dependent on the ham gene cluster. Antifungal activity of the 
wild type (H111 wt), the hamD mutant (H111 ΔhamD), the hamF mutant (H111 ΔhamF) and 
the trans-complemented mutants (H111 ΔhamD pBBRhamD and H111 ΔhamF pBBRhamF) 
against A) Fusarium solani and B) Rhizoctonia solani. Area of inhibition refers to the 
difference in the plate surface covered with the fungus in the presence and absence of 
bacteria. Results are represented as means ± SD derived from at least 3 independent 
experiments. Representative pictures of the antifungal assays are shown below the 
respective bars. C) Antifungal activity is lost in single ham deletion mutants and restored by 
expression of the respective gene from a plasmid. Representative pictures of antifungal 
spray assays against the fungus F. solani are shown.  
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2.6 Fragin is the biosynthetic product of the ham cluster and 
the main antifungal compound of strain H111 
After establishing that the ham cluster is essential for antifungal activity of B. 
cenocepacia H111, I attempted to identify the chemical nature of the antifungal 
molecule synthesized by the ham cluster. As described above, the genes of the ham 
cluster encode for an NRPS-like assembly line. Protein domain predictions for the 
ham genes suggest that the synthesized molecule is most likely a leucine or 
phenylalanine condensed with a fatty acid. Furthermore, the presence of the AurF-
like protein encoded by hamC suggests that the structure might also contain a 
nitrogen group. To elucidate the structure of the biosynthetic product of the ham 
genes, the putative antifungal molecule was extracted from agar plates and ABG 
minimal broth cultures and the extracts were tested for antifungal activity. Extracts 
from the wildtype strain showed a clear inhibition of fungal rowth on MEA plates, 
while extracts from a hamD mutant did not inhibit fungal growth (Figure 9A).  
To lower the complexity of the organic solvent extracts, a bioassay guided 
fractionation was carried out. Chloroform extracts of H111 wt and H111 ΔhamD were 
separated by TLC and the plate was divided into 14 sections. The stationary phase of 
the TLC plate was scraped off and re-extracted with methanol. All 14 fractions where 
then tested for their antifungal activity and the fraction with the highest antifungal 
activity (fraction 9) in the wildtype strain (Figure 9B) was used for high-performance 
liquid chromatography mass spectrometry (HPLC-MS) analysis. The corresponding 
fraction from H111 ΔhamD was also subjected to HPLC-MS analysis. The HPLC-MS 
spectra of fractions from the H111 wild type and the H111ΔhamD mutant were 
compared and a compound eluting with a retention time of 20.4 min was exclusively 
found in the wild type extract (Figure 9C). The compound was isolated by RP-HPLC 
using a Gemini-NX column, concentrated 200-fold and tested for its antifungal activity 
in a fungal spray assay as described above. As seen in Figure 9D, the isolated 
compound showed strong antifungal activity against the fungal model strain F. solani. 
The bioactive compound was further analysed by HPLC-MS and showed an m/z of 
274.2 Da in positive mode and an m/z of 272.2 Da in negative mode, which 
suggested a molecular mass of 273.2 Da for the isolated compound. 
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Figure 9 : Extraction and purification of the main antifungal metabolite from B. cenocepacia 
H111. A) Antifungal activity of concentrated chloroform extracts from wild type (H111 wt) and 
hamD mutant (H111 ΔhamD) cultures. B) Test for antifungal activity of the extracted 
antifungal compound after fractionation. Fractionation was carried out by TLC. The TLC plate 
was divided into 14 sections and antifungal compound(s) were recovered by methanol 
extraction. Fractions are labeled with numbers 1 to 14 and activities compared to that of the 
crude extract (crude). C) HPLC chromatograms of fraction 9 from the wild type strain (H111 
wt) and the hamD mutant (H111 ΔhamD) show a distinct peak present in the wild type 
extract. The HPLC-MS chromatogram of the isolated peak from the wild type extract shows 
an m/z of 272 Da. D) Bioassay to confirm the antifungal activity of the HPLC-purified 
compound from fraction 9 of the wild type extract (HPLC peak). The isolated compound 
showed strong antifungal activity, comparable to the crude extract of the wild type culture. 
Representative pictures of an antifungal spray assay against the fungus F. solani are shown. 
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The structure of the compound was further determined by 1H-NMR spectroscopy and 
together with the HPLC-MS measurements, the data are in agreement with the 
structure shown in Figure 10A, which resembles fragin, an antifungal compound 
which was first isolated from Pseudomonas fragi in 1967 [218]. The proposed 
structure of fragin was confirmed with a single crystal X-ray analysis of the isolated 
natural product. The obtained crystal structure of fragin was confirmed with 
chemically synthesized fragin. In addition, an enantioselective total synthesis was 
developed and single crystal X-ray analysis showed that the naturally produced fragin 
from B. cenocepacia H111 is in the D-configuration. 
 
To confirm the antifungal activity of fragin, disc diffusion assays of chemically 
synthesized L- and D-fragin against the fungus F. solani and several Gram-positive 
and Gram-negative bacteria were performed. Both enantiomers showed antifungal 
activity against F. solani, but the activity of the naturally occurring D-fragin was higher 
than that of L-fragin (Figure 10B). Furthermore, both fragin enantiomers showed 
growth inhibition of Gram-positive bacteria, while none of the tested Gram-negative 
bacteria were inhibited (Figure 10C and 10D).   
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Figure 10 :Structure and bioactivity of the secondary metabolite synthesized by the ham 
cluster. A) Structure of fragin, the antifungal metabolite produced by the ham cluster. The 
molecule structure was drawn with the Marvin Sketch software from ChemAxon. B) Disc 
diffusion assays of synthetic D- and L-fragin to determine the antifungal activity. 
Representative pictures of an antifungal spray assay against the fungus F. solani are shown. 
C) Disc diffusion assay of 20 µg synthetic D- and L-fragin to determine activity against the 
Gram-positive bacteria Bacillus cereus, Bacillus subtilis, Bacillus thuringiensis, 
Staphylococcus aureus and the yeast Saccharomyces cerevisiae. D) Disc diffusion assay of 
20 µg synthetic D- and L-fragin to determine  activity against the Gram-negative bacteria 
Chromobacterium violaceum, Eschericia coli ATCC, E. coli K-12, Klebsiella oxytoca and 
Pseudomonas syringae. Representative pictures are shown for all disc diffusion assays 
 
 
Several bioinformatic tools had predicted that the A domain of HamD was most likely 
to incorporate phenylalanine or leucine into the antifungal compound. Based on the 
structure of fragin, phenylalanine is a very unlikely substrate. To clarify whether 
leucine or possibly valine is the precursor of fragin, feeding studies with C13- and N15-
labeled L-valine and L-leucine were carried out. Labeled L-valine or L-leucine was 
fed to H111 wild-type cultures over a period of 72 hours and fragin was subsequently 
extracted from the cultures and analysed by ESI-MS. This analysis revealed that 
approximately 4 % of the C13- and N15-labeled L-leucine, 5.5 % of the N15-labeled L-
valine, and nearly 10 % of the C13-labeled L-valine were incorporated into fragin 
(Table 4). Feeding with N15 labeled L-leucine and L-valine also showed incorporation 
into the siderophore pyochelin, suggesting that the N15 enters the nitrogen cycle of 
the cell.  
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Table 4: Incorporation rate of isotopically labeled amino acids into fragin. 
 mass relative intensity % labeled 
fragin 
L-valine 15N      
recorded value      
C13.H27.O3.N3.Na 296.19405 100  
C13.H27.O3.N2.15N.Na 297.19114 7.02  
       
calculated value      
C13.H27.O3.N3.Na 296.19446 100  
C13.H27.O3.N2.15N.Na 297.1915 1.11  
   5.58 
L-leucine 15N      
recorded value      
C13.H27.O3.N3.Na 296.19398 100  
C13.H27.O3.N2.15N.Na 297.1911 5.55  
       
calculated value      
C13.H27.O3.N3.Na 296.19446 100  
C13.H27.O3.N2.15N.Na 297.1915 1.11  
   4.25 
L-valine 13C5      
recorded value      
C13.H27.O3.N3.Na 296.19408 100  
C8.13C5.H27.O3.N3.Na 301.21081 10.77  
       
calculated value      
C13.H27.O3.N3.Na 296.19446 100  
C8.13C5.H27.O3.N3.Na 301.21081 0  
   9.72 
L-leucine 13C      
recorded value      
C13.H27.O3.N3.Na 296.19411 100  
C12.13C.H27.O3.N3.Na 297.1974 19.07  
       
calculated value      
C13.H27.O3.N3.Na 296.19411 100  
C12.13C.H27.O3.N3.Na 297.1974 14.49  
   4.38 
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The experiments in this section were performed in collaboration with the Group of 
Prof. Karl Gademann, University of Zurich and University of Basel. HPLC-MS and 1H-
NMR spectroscopy were performed by Simon Sieber. Chemical synthesis of fragin 
was developed and performed by Christophe Daeppen. Incorporation of isotopically 
labeled amino acids was determined by the mass spectrometry service at the 
University of Zurich. 
 
2.7 The ham cluster is essential for yellow colony phenotype 
under high iron concentrations 
While trying to optimize the growth conditions for antifungal activity and production of 
the antifungal compound, we noticed that addition of excess iron to the medium 
resulted in the formation of yellow colonies on agar plates. B. cenocepacia is known 
to produce two different siderophores, pyochelin and ornibactin. To see if the yellow 
colony phenotype was dependent on the presence of either of the two siderophores, 
a pyochelin mutant (H111 ΔpchAB), an ornibactin mutant (H111 ΔorbJ) and a double 
mutant (H111 ΔpchAB ΔorbJ) were screened for the appearance of the yellow colony 
phenotype in the presence of different amounts of iron. While no change in colony 
color was observed in the H111 wild-type strain or the siderophore mutants in the 
presence of 10 µM iron, all four strains exhibited the yellow colony phenotype when 
incubated on MEA plates supplemented with 100 µM iron (Figure 11A). To see if the 
yellow colony phenotype was under the control of a regulatory system known to 
influence the expression of the ham cluster, strains H111 ΔpC3, H111 ΔcepIR and 
H111 ΔcepR2 were tested for the yellow colony phenotype in presence of iron. As 
shown in Figure 11B, all three mutants lost their ability to form yellow colonies in the 
presence of 100 µM iron. As all three mutants are either defective in the expression 
of the ham cluster (H111 ΔpC3, H111 ΔcepIR) or have lowered antifungal activity 
(H111ΔpC3, H111 ΔcepIR and H111 ΔcepR2), the ham cluster probably plays an 
important role in the development of the yellow colony phenotype. Therefore a hamD 
mutant (H111 ΔhamD) along with a genetically complemented derivative (H111 
ΔhamD/pBBRhamD) and the respective empty vector control (H111 ΔhamD/pBBR) 
were also tested for their ability to form yellow colonies in the presence of high 
amounts of iron. Indeed, mutation of hamD led to the loss of the yellow colony 
phenotype in the presence of 100 µM iron and was restored when hamD was 
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expressed in trans from a plasmid (Figure 11C). As expected, the yellow colony 
phenotype was not restored in the empty vector control strain (Figure 11C). These 
experiments established a clear connection between the iron-dependent yellow 
colony phenotype and the ham cluster.  
 
 
Figure 11 : Development of the yellow colony phenotype of B. cenocepacia H111 on agar 
plates supplemented with excess iron. A) The pyochelin (H111 ΔpchAB), ornibactin (H111 
ΔorbJ) and double (H111 ΔpchAB ΔorbJ) mutants develop a yellow colony phenotype in the 
presence of 100 µM FeCl3 on malt extract agar (MEA) plates.  B) Mutation of cepIR (H111 
ΔcepIR) and the solo LuxR regulator gene cepR2 (H111 ΔcepR2), prevent the development 
of the yellow colony phenotype. Loss of megaplasmid pC3 (H111 ΔpC3) leads to a less 
pronounced yellow color formation. C) Mutation of hamD (H111 ΔhamD) results in the loss of 
yellow colony formation, which is restored by expression of hamD from a plasmid (H111 
ΔhamD pBBRhamD). No restoration of yellow colony formation was observed in the empty 
vector control (H111 ΔhamD pBBR). Representative pictures are shown for all bacteria 
grown on MEA plates with and without FeCl3.  
 
2.8 High iron concentrations diminish antifungal activity of B. 
cenocepacia 
As antifungal activity as well as the development of the iron-dependent yellow colony 
phenotype, were both dependent on the ham cluster, it was of interest to know if iron 
influences the antifungal activity of B. cenocepacia H111. The H111 wild type strain 
along with several mutants impaired in antifungal activity and yellow colony formation 
(H111 ΔcepIR, H111 ΔcepR2, H111 ΔpC3 and H111 ΔhamD) were tested for their 
antifungal activity under different iron concentrations. As controls, the in trans 
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complemented hamD mutant (H111 ΔhamD/pBBRhamD) and the empty vector strain 
(H111 ΔhamD/pBBR) were also tested for their antifungal activities under the same 
condition. The antifungal spray assay confirmed the yellow colony phenotype 
described above. Antifungal activity of the H111 wild type, H111 ΔcepIR, H111 ΔpC3 
and H111 ΔhamD/pBBRhamD was lowered in the presence of 1 µM additional iron 
and was completely lost when the bacteria where grown in with 10 µM iron (Figure 
12A). H111ΔcepR, H111ΔhamD and H111ΔhamD/pBBR did not exhibit antifungal 
activity, irrespective of the iron concentration in the agar plate (Figure 12A).  
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Figure 12: Antifungal activity is lost in 
the presence of excess amounts of iron. 
A) Addition of 1 µM FeCl3 diminishes 
antifungal activity while addition of 10 
µM FeCl3 completely abrogates 
antifungal activity in the wild type strain 
(H111 wt), the pC3 negative derivative 
(H111 ΔpC3), the CepIR quorum 
sensing mutant (H111 ΔcepIR) and the 
complemented hamD mutant (H111 
ΔhamD pBBRhamD). B) Mutation of 
genes involved in pyochelin (H111 
ΔpchAB) and ornibactin (H111 ΔorbJ) 
biosynthesis resulted in a slight 
reduction in antifungal activity, while 
mutation of both siderophores (H111 
ΔpchAB ΔorbJ) resulted in highly 
reduced antifungal activity. Addition of 
excess iron led to a reduction of 
antifungal activity at 1 µM FeCl3, and its 
complete loss at 10 µM FeCl3 in all three 
mutant strains. Representative pictures 
of antifungal spray assays against the 
fungus F. solani are shown. 
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2.9 Antifungal activity is influenced by the presence of 
siderophores 
Although high iron concentrations lowered antifungal activity (Figure 12A), the iron-
induced yellow colony phenotype was not influenced in H111 derivatives deficient for 
pyochelin and ornibactin production (Figure 11A). Therefore a connection between 
antifungal activity and siderophore production was not apparent. Nevertheless, 
siderophores restrict iron availability for competing microbes and the pyochelin 
precursor dihydro aeruginoic acid (Dha) is a known antifungal compound [219]. 
Therefore it was of interest to see if pyochelin and ornibactin have an influence on 
antifungal activity of H111 under the conditions of the antifungal spray assay. While 
mutation of the pyochelin biosynthesis genes pchAB did not influence antifungal 
activity, mutation of orbJ, which is required for ornibactin biosynthesis, clearly 
reduced antifungal activity (Figure 12B). An H111 mutant strain deficient in the 
biosynthesis of both siderophores (H111 ΔpchABΔorbJ) was nearly devoid of 
antifungal activity (Figure 12B). Importantly, supplementation with 1 µM and 10 µM 
iron diminished antifungal activity even further (Figure 12B), which is in agreement 
with the observed reduction of antifungal activity in the wild-type strain in the 
presence of high iron concentrations (Figure 12A). Taken together, the presence of 
the two siderophores pyochelin and ornibactin is necessary for full antifungal activity 
of H111. High concentrations of iron have a negative effect on antifungal activity of B. 
cenocepacia H111, probably by downregulating siderophore production.  
 
2.10 Antifungal activity and yellow colony formation are linked 
in strain K56-2 
As previously established, CepR2 is a negative regulator of antifungal activity in B. 
cenocepacia K56-2 and a positive regulator of antifungal activity in B. cenocepacia 
H111. To test whether the yellow colony phenotype was similarly inversely regulated 
by CepR2, the K56-2 wt and cepR2 mutant strains thereof were tested for antifungal 
activity and yellow colony phenotype on standard MEA plates and MEA plates 
supplemented with 100 µM FeCl3. Antifungal activity was lowered by addition of iron 
in K56-2 wt and K56-2 ΔcepR2. In contrast to H111, the K56-2 wild-type strain 
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remained white in the presence of 100 µM iron, while the cepR2 mutant showed the 
yellow colony phenotype (Figure 13). This supports our finding that the K56-2 cepR2 
mutant exhibits increased antifungal activity (Figure 7) and is in agreement with 
previously published data showing that CepR2 is a positive regulator of the ham 
cluster in strain H111 [55]. Accordingly, higher amounts of fragin are expected to be 
produced by H111 wild-type and K56-2 ΔcepR2 compared to H111 ΔcepR2 and 
K56-2 wild-type. 
 
Figure 13: Antifungal activity of strain K56-2 is  reduced under high iron concentrations. 
Addition of 100 µM FeCl3 to agar plates led to the formation of yellow colony phenotype 
along with a reduction in antifungal activity in the cepR2 mutant derivative of strain K56-2 
(K56-2 ΔcepR2). Only a very slightly yellow colony phenotype was observed for the K56-2 
wild type (K56-2 wt). Representative pictures of antifungal spray assays against the fungus 
F. solani are shown. 
 
2.11 The antifungal activity of fragin is inhibited by iron in vitro 
N-nitrosohydroxylamines were shown to chelate metals and inhibit enzymes which 
have metals in their active center [220, 221]. It is plausible that the antifungal and 
antibacterial activities of fragin are at least partially due to its metal chelating 
properties. In this context, reduction of antifungal activity by excess iron might be due 
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to saturation of fragin with free iron, rendering fragin inactive. To test this possibility, 
chloroform extracts of H111 wild-type and H111 ΔhamD cultures grown under fragin 
producing conditions, were extracted with chloroform and concentrated 100-fold. The 
concentrated extracts were either spotted on agar plates containing 100 µM iron or 
were incubated overnight with different amounts of iron and then spotted on standard 
MEA plates and tested for antifungal activity. Bacterial extracts spotted on agar 
plates containing 100 µM additional iron showed lowered antifungal activity 
compared to extracts spotted on standard agar plates (Figure 14A).  Furthermore, 
overnight incubation of bacterial extracts with high amounts of iron resulted in clearly 
lowered antifungal activity (Figure 14B). These experiments indicate that iron directly 
interferes with fragin activity. 
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Figure 14: Iron reduces the antifungal activity of fragin in vitro. A) Chloroform extracts 
derived from H111 wild type cultures showed highly reduced antifungal activity when spotted 
on agar plates containing high amounts of iron (agar plate 100 µM FeCl3) compared to 
standard agar plates (agar plate 0µM FeCl3). B) Chloroform extracts derived from H111 wild 
type cultures showed reduced antifungal activity when pre-incubated with iron overnight 
(supplementation with 100 µM FeCl3) compared to untreated extracts (no FeCl3 
supplementation). Representative pictures of antifungal spray assays against the fungus F. 
solani are shown. 
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2.12 Identification of regulators affecting ham gene expression 
by transposon mutagenesis 
All mutants that did not show the yellow colony phenotype in the presence of excess 
amounts of iron were also reduced in, or completely devoid of, antifungal activity. 
Therefore the yellow colony phenotype was used as the readout for a transposon 
mutant library screen. In brief, the transposon mutant library was plated on MEA 
plates supplemented with 100 µM FeCl3 and screened for white colonies (i.e. 
putatively fragin negative) and bright yellow colonies (i.e. putatively fragin 
overproducing). Positive mutants where tested for antifungal activity and their 
transposon insertion siteswere mapped by arbitrary PCR and sequencing. The 
transposon insertion sites of the clones derived from white colonies were mapped to 
cepS, hamF and I35_0679, a LysR-type regulator encoded on chromosome 1. Three 
clones showed a bright yellow colony phenotype and the transposon insertion sites 
for all three mutants were mapped to the gene I35_4197, which encodes an AraC 
regulator and is located next to the ham gene cluster. As expected, the three 
transposon mutants with the white colony phenotype showed highly reduced 
antifungal activity while the transposon mutant with the bright yellow colony 
phenotype showed increased antifungal activity relative to the wild type strain 
(Figures 15A and 15B).  
To further characterize these transposon mutants, they were tested on CAS plates 
(siderophore production), YEM plates (EPS production) and skim milk plates 
(protease production). The hamF transposon mutant showed clearly reduced 
siderophore production, slightly reduced protease activity and EPS production 
comparable to the wild-type strain. Both, the cepS and the lysR (I35_0679) mutants 
showed reduced siderophore production comparable with the hamF mutant, and EPS 
production similar to the wild-type strain. While the cepS transposon mutant showed 
similar protease activity to the wild-type, the lysR mutant had greatly reduced 
protease activity (Figure 15A). 
The araC mutant (I35_4197) had similar protease activity and EPS production to the 
wild-type. Siderophore production, as assessed on CAS plates, was clearly increased 
in the araC mutant compared to the wild-type strain (Figure 15B). 
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Figure 15 : Altered antifungal activity and additional phenotypic characterization of several 
transposon mutants. A) Antifungal activity is reduced in a hamF (H111 hamF::Tn5), a cepS 
(H111 cepS::Tn5) and a lysR (H111 lysR::Tn5) transposon mutant.  Phenotypic changes in 
the transposon hamF, cepS and lysR mutants with regard to siderophore production (CAS 
plates), EPS production (YEM plates) and protease secretion (skim milk plates) compared to 
the H111 wild type strain. B) Transposon insertion into I35_4197 (H111 araC::Tn5) resulted 
in elevated antifungal activity.  Phenotypic changes in the transposon araC mutant with 
regard to siderophore production (CAS plates), EPS production (YEM plates) and protease 
secretion (skim milk plates) compared to the H111 wild type strain. Representative pictures 
are shown. 
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3 Results II: Cell – Cell Communication  
 
3.1 The ham genes are positively regulated by CepR2 and 
CepS 
The solo LuxR-type regulator CepR2 negatively regulates the expression of the ham 
cluster in B. cenocepacia K56-2 [55]. In agreement with this, antifungal activity is 
negatively regulated by CepR2 in strain K56-2, while CepR2 is a positive regulator of 
antifungal activity in strain H111 (Figure 7A). In addition, CepS is a positive regulator 
of antifungal activity in strain H111 (Figure 15A). To ascertain the role of CepR2 and 
CepS in the regulation of the ham genes, a transcriptional fusion of the hamA 
promoter (PhamA) and the hamF promoter (PhamF) to lacZ were introduced into 
H111 wild-type (H111/PhamA–lacZ and H111/PhamF–lacZ), a cepR2 mutant (H111 
cepR2::pEX18/PhamA–lacZ and H111 cepR2::pEX18/PhamF–lacZ) and a cepS 
mutant (H111 cepS::Tn5Km/PhamA–lacZ and H111 cepS::Tn5Km/PhamF–lacZ) and 
β-galactosidase activities were determined. The activity of both the hamA and the 
hamF promoters was markedly reduced in the cepR2 and the cepS mutants. As 
expected, the empty vector controls showed no β-galactosidase activity (Figure 16). 
These data show that both CepR2 and CepS are positive regulators of the ham 
genes in strain H111.  
 
Chapter II: Results 
52 
 
 
Figure 16 : Both ham operons are regulated by CepR2 and CepS. Beta-galactosidase 
assays of the promoters of the hamACBDE (PhamA-lacZ) and the hamFG (PhamF-lacZ) 
operon in the wild type strain (H111 wt), as well as in a cepR2 (H111 cepR2 ::pEX18) and a 
cepS (H111 cepS ::Tn5) mutant showed that CepR2 and CepS positively regulate both ham 
operons. Empty vector controls showed no background activity. Results are presented as 
means ± SD from at least 3 independent biological replicates measured in technical 
triplicates. 
 
3.2 A subset of the ham genes synthesizes a novel 
autoinducer molecule 
The pvf cluster of P. entomophila, and the mgo cluster of P. syringae pv. syringae 
UMAF0158, are homologues of the ham cluster, but lack hamB and the hamFG 
operon (Figure 4).  These clusters were shown to produce an extracellular signaling 
molecule of unknown structure [216, 217]. This suggested that the expression of the 
ham cluster may be under the control of a self-generated signal which is synthesized 
by a subset of the ham genes. In analogy to the pvf and mgo clusters, this signaling 
molecule is predicted to be synthesized by mutants lacking hamB, hamF or hamG, 
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but not when other ham genes are mutated. To test this possibility a transcriptional 
fusion of the hamA promoter (PhamA) to lacZ was introduced into H111 wild-type 
and H111 ΔhamD and hamA promoter activity was estimated on agar plates. The 
promoter activity was markedly reduced in the hamD mutant relative to the wild type 
strain (Figure 17). Importantly, cross streak experiments showed that hamA promoter 
activity was restored when H111 wild-type was streaked next to H111 
ΔhamD/PhamA–lacZ, suggesting that the ham cluster synthesizes an extracellular 
cell-cell signaling molecule (Figure 18A). To ascertain the genes required for 
synthesis of this extracellular cell-cell signaling molecule, all ham mutants were 
tested for their ability to induce the activity of the hamA promoter in cross-streak 
experiments. In full agreement with published work on the mgo and pvf clusters of P. 
syringae pv syringe UMAF0158 and P. entomophila, mutations in hamB, hamF and 
hamG did not affect the induction of the hamA promoter, while mutants deficient in 
hamA, hamC, hamD or hamE did not induce the hamA promoter (Figure 18A).  
 
 
Figure 17: The ham genes are regulated by a positive feedback loop. Representative 
pictures of the promoter activity of the hamABCDE operon (PhamA-lacZ) in the wild type 
(H111 wt) and a hamD mutant (H111 ΔhamD) background observed on agar plates 
supplemented with 40 µg/ml X-gal as substrate. The promoter activity is clearly higher in the 
wild type background than in the hamD mutant background, as seen by the blue coloration of 
the wild type bacterial colony. Empty vector controls with pSU11 (empty vector) showed no 
background promoter activity in both strains.  
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To visualize the production of the extracellular signaling molecule, a TLC overlay 
assay was developed. Organic solvent extracts of H111 wild-type and the seven ham 
mutant derivatives were separated by TLC and then overlayed with agar containing 
the H111ΔhamD/PhamA–lacZ reporter strain. As shown in Figure 18B, extracts from 
strains H111 wild-type, H111 ΔhamB, H111 ΔhamF and H111ΔhamG showed a 
distinct spot in the TLC overlay assay, indicating activation of the hamA promoter by 
a diffusible signaling molecule. This confirms the results from the cross-streak 
experiments, showing that the ham gene homologues to the mgo and pvf genes are 
essential for the biosynthesis of the uncharacterized signaling molecule. The 
signaling molecule derived from the hamF mutant strain showed a different migration 
pattern on the TLC plate to those of the wildtype strain and the hamB and hamG 
mutants. The concentration of small molecules can influence their migration pattern. 
Therefore different amounts of H111 wild-type and H111 ΔhamF extracts were 
analyzed. As can be seen in Figure 18C, migration of the signaling molecule is 
indeed dependent on its concentration. Therefore the difference seen in Figure 18B 
can be attributed to a higher concentration of the signaling molecule in the hamF 
mutant.  
Given that all ham genes are required for fragin biosynthesis (Figure 8C), fragin itself 
cannot be the molecule responsible for induction of the hamA promoter, suggesting 
that the ham cluster directs the synthesis of two discrete molecules.  
Based on the predicted functions of the HamF and HamG encoded proteins, the 
putative signaling molecule was thought likely to be structurally similar to fragin, but 
would lack the acyl chain and the amino group introduced by HamG. We also 
speculated that fragin might mask the presence of the signaling molecule. H111 
ΔhamF is fragin-negative (Figure 8), but still induced the hamA promoter (Figure 
18A). Therefore the H111 ΔhamF strain was chosen for the identification of the 
putative signaling molecule.   
  
Chapter II: Results 
55 
 
 
Chapter II: Results 
56 
 
Figure 18: The ham gene cluster synthesizes a signaling molecule which acts in a positive 
feedback loop. A) Cross-streaks of all seven ham gene mutants with the reporter strain 
(H111 ΔhamD/PhamA-lacZ) showed that hamB, hamF and hamG are dispensable for the 
production of the signal molecule. B) TLC overlay assay of dichloromethane extracts from 
culture supernatants of the wild type strain and all ham mutants. C) TLC overlay assay of 
dichloromethane extracts from the wild type strain (H111 wt) and the hamF mutant strain 
(H111 ΔhamF). Different volumes of extracts were spotted on the TLC plates (high to low 
volumes from left to right), resulting in a concentration gradient of the signaling molecule 
(indicated by an arrow on the bottom labeled with concentration).  The migration pattern of 
the signaling molecule was dependent on the concentration of the signaling molecule. All 
TLC plates were overlayed with agar containing 40 µg/ml X-gal and the reporter strain H111 
ΔhamD/PhamA-lacZ. Blue spots indicated the presence of the ham-derived signaling 
molecule. 
 
3.3 Valazole is a novel signaling molecule synthesized by B. 
cenocepacia H111 
Attempts to lower the complexity of the H111ΔhamF solvent extract by TLC 
separation and re-extraction of the signaling molecule with subsequent HPLC-MS 
analysis did not allow us to unequivocally assign a molecular mass to the unknown 
signaling molecule, due to very low yields after re-extraction from the TLC plate 
(Figure 19A). Therefore a simple basic-acid work up protocol was established with 
the help of Simon Sieber (Group Prof. Karl Gademann). Cell-free supernatants of 
H111 ΔhamD and H111 ΔhamF were first alkalized to pH 11, and extracted with 
CHCl2. The aqueous phase was subsequently acidified to pH 5 and extracted again 
with CHCl2. The organic phase was concentrated and tested for the presence of the 
ham derived signaling molecule with a TLC overlay assay. As shown in Figure 19B, 
the organic solvent extract derived from the pH 5 aqueous phase contained the 
signaling molecule as expected. The crude extract was subsequently purified by 
HPLC and a compound eluting with a retention time of 9.83 minutes was identified as 
the putative signaling molecule. The structure of the signaling compound was 
determined by 1H- and 13C-NMR spectroscopy and X-ray crystal structure analysis by 
Christophe Daeppen (Group Prof. Karl Gademann, University of Zurich). This novel 
signal molecule was named valazole (Figure 19D). The structure of valazole was 
confirmed by 1H- and 13C-NMR spectroscopy and X-ray crystal structure analysis of 
synthetic valazole (synthesis was carried out by Christophe Daeppen, Group Prof. 
Karl Gademann, University of Zurich).   
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Figure 19 : Extraction and structure of the ham-derived signaling molecule valazole. A) 
Extracted ham derived signaling molecule from the H111 wild type strain (H111 wt extract) 
and the re-extracted signaling molecule from a previously performed TLC separation. B) 
Chloroform extracts derived from culture supernatants of the H111 wildtype strain alkalized 
to pH11 (H111 wt extract pH11) and subsequently acidified to pH5 (H111 wt extract pH11 -> 
pH5). C) Chloroform extract of a hamF mutant culture supernatant after acid-base workup 
shows the presence of the ham-derived signaling molecule. All TLC plates were overlayed 
with agar containing  40 µg/ml X-gal and the reporter strain H111 ΔhamD/PhamA-lacZ. Blue 
spots indicated the presence of the ham-derived signaling molecule. Representative pictures 
are shown. D) Structure of valazol, the ham-derived signaling molecule, which was 
determined by 1H-NMR and X-ray crystal structure analysis. 
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3.4 Valazole regulates the expression of the ham cluster and 
neighboring genes 
To confirm that valazole stimulates the activity of the hamA promoter and to test 
whether the hamFG operon is also regulated by valazole we measured β-
galactosidase activities of respective transcriptional lacZ promoter fusions in the wild-
type as well as in a hamD (fragin and valazole negative) and a hamF (fragin 
negative) mutant background. While the activities of the two promoters were virtually 
indistinguishable between the wild type and the hamF mutant strain, they were 
greatly reduced in the hamD mutant. Addition of D-valazole to the growth medium 
restored β-galactosidase activities in the hamD mutant background in a dose-
dependent manner, reaching the level of the wild-type at a concentration of 50 µM 
(Figure 20). These results demonstrate that valazole is a novel signal molecule that 
positively regulates its own production. 
 
 
Figure 20 : The ham genes are regulated by valazole in a concentration-dependent manner. 
A) The promoter activity of the hamABCDE operon (PhamA-lacZ) was comparable in the wild 
type strain (H111 wt) and the hamF mutant strain (H111 ΔhamF). The hamD mutant strain 
(H111 ΔhamD) showed only very low promoter activity, which could be activitated by the 
addition of synthetic valazole. B)The promoter activity of the hamFG operon (PhamF-lacZ) 
was comparable in the wild type strain (H111 wt) and the hamF mutant strain (H111 ΔhamF). 
The hamD mutant strain (H111 ΔhamD) showed only very low promoter activity which could 
be activitated by the addtion of synthetic valazole. Results are presented as means ±SD from 
three independent biological replicates carried out in technical triplactes. 
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To identify the valazole regulon in B. cenocepacia H111 we performed RNA-Seq 
analyses of the wild-type strain, the hamD mutant in the presence and absence of 
100 µM D-valazole, and the genetically complemented hamD mutant. Expression of 
112 genes was found to be > 3-fold lower in the H111 ΔhamD mutant relative to the 
wild-type (Table 5). Most remarkable among these differentially regulated genes was 
a cluster of sixteen genes consisting of the two ham operons plus genes in their 
vicinity. These valazole-regulated genes code for CepR2 (I35_4186), CepS 
(I35_4187),a LysR-type regulator (I35_4196), a LeuA homolog (I35_4185), a tripartite 
multidrug resistance system (I35_4198 – I35_4200), a hypothetical protein 
(I35_4201) and a TRP repeat protein (I35_4202). CepR2 and CepS are positive 
regulators of the ham cluster and are required for expression of antifungal activity 
(see above and in [55]). LeuA is a 2-isopropylmalate synthase and catalyzes the first 
step in leucine biosynthesis at the branching point from valine biosynthesis by 
converting 3-methyl-2-oxobutanoate to (2S)-2-isopropylmalate. The tripartite efflux 
system might be involved in fragin or valazole secretion, which remains to be 
investigated in the future. 
Moreover, valazole also positively affected the expression of genes that are not 
physically connected to the ham cluster. Several of these genes are either involved in 
metal transport or homeostasis or rely on metals for their enzymatic activity. The 
proteins involved in metal transport and homeostasis are the nickel chaperon UreG 
(I35_0764), a cobalt-zinc-cadmium resistance protein (I35_4611) and a multicopper 
oxidase (I35_4350). In addition, several proteins that use metals for their enzyme 
activity are also regulated, among them two putative IlvD homologs (I35_2532 and 
I35_7391), an L-arabonate dehydratase (I35_6680), a cysteine desulfurase 
(I35_4435) and the nitrate reductase NirB (I35_5547), all of which have Fe-S clusters 
in their active center. 
Besides the aforementioned LeuA homolog I35_4185, another five valazole-
regulated gene products are predicted to be involved in the metabolism of 3-methyl-
2-oxobutanoate. Two are putative LeuA homologs (I35_4642 and I35_2881), two are 
putative IlvD homologs (I35_2532 and I35_7391) and the last one is predicted to be a 
PanB (I35_4373) homolog. In addition to its role in isoleucine biosynthesis, IlvD also 
catalyzes the reaction of (2R)-2,3-dihydroxy-3-methylbutanoate to 3-methyl-2-
oxobutanoate, which is a substrate for LeuA and also for PanB, which converts it to 
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2-dehydropropantoate.  
 
Table 5: Genes with statistically significant decreased expression (pval<0.1) above the 
threshold (>3-fold change) in H111 ΔhamD (hamD) compared to H111 wildtype (wt). ND: not 
applicable because read number for hamD was 0.  
Name locus_tag fold change hamD vs wt 
hppD I35_0198 0.219 
paaG I35_0207 0.246 
yrbE I35_0293 0.298 
pilB I35_0430 0.004 
pntAB I35_0549 0.119 
hmpA I35_0589 0.128 
ureG I35_0764 0.113 
ureC I35_0767 0.104 
ureB I35_0768 0.059 
I35_0773 I35_0773 0.104 
I35_0775 I35_0775 0.243 
I35_0802 I35_0802 ND 
I35_0923 I35_0923 0.154 
mdtB I35_1072 0.253 
I35_1077 I35_1077 0.111 
I35_1214 I35_1214 0.125 
I35_1298 I35_1298 0.020 
fsr I35_1349 0.314 
truB I35_1407 0.105 
I35_1420 I35_1420 0.131 
I35_1421 I35_1421 0.091 
I35_1680 I35_1680 0.238 
I35_1972 I35_1972 0.090 
I35_2020 I35_2020 0.138 
aceA I35_2045 0.169 
I35_2050 I35_2050 ND 
hutU I35_2172 0.296 
cysNC I35_2189 0.212 
kdpB I35_2306 0.068 
kdpA I35_2307 0.080 
ilvD I35_2532 0.177 
I35_2661 I35_2661 0.302 
leuA I35_2881 0.146 
I35_3015 I35_3015 0.235 
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I35_3278 I35_3278 ND 
I35_4013 I35_4013 ND 
I35_4014 I35_4014 ND 
I35_4113 I35_4113 ND 
leuA I35_4185 0.080 
cepR2 I35_4186 0.102 
cepS I35_4187 0.179 
I35_4188 I35_4188 0.143 
I35_4189 I35_4189 0.146 
I35_4191 I35_4191 0.032 
I35_4192 I35_4192 0.023 
I35_4193 I35_4193 0.026 
I35_4194 I35_4194 0.001 
I35_4195 I35_4195 0.083 
I35_4196 I35_4196 0.038 
I35_4198 I35_4198 0.031 
emrA I35_4199 ND 
I35_4200 I35_4200 0.028 
I35_4201 I35_4201 0.040 
I35_4202 I35_4202 0.094 
I35_4287 I35_4287 ND 
I35_4289 I35_4289 ND 
I35_4350 I35_4350 0.079 
panB I35_4373 0.124 
I35_4388 I35_4388 ND 
I35_4434 I35_4434 0.131 
I35_4435 I35_4435 0.216 
I35_4500 I35_4500 0.308 
I35_4557 I35_4557 ND 
I35_4593 I35_4593 0.173 
I35_4611 I35_4611 0.316 
I35_4625 I35_4625 0.243 
I35_4639 I35_4639 0.262 
lysR I35_4640 0.079 
lysR I35_4641 0.201 
leuA I35_4642 0.079 
bceC I35_4769 0.148 
I35_5255 I35_5255 0.217 
I35_5295 I35_5295 0.319 
I35_5296 I35_5296 0.314 
I35_5517 I35_5517 ND 
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I35_5529 I35_5529 0.031 
I35_5530 I35_5530 0.149 
nirB I35_5547 0.070 
I35_5720 I35_5720 ND 
cmeB I35_5771 0.245 
I35_5857 I35_5857 0.316 
I35_5869 I35_5869 ND 
I35_5874 I35_5874 0.170 
I35_5938 I35_5938 0.263 
I35_5941 I35_5941 ND 
I35_6021 I35_6021 0.252 
I35_6175 I35_6175 0.192 
I35_6268 I35_6268 0.008 
I35_6332 I35_6332 0.161 
I35_6416 I35_6416 ND 
I35_6430 I35_6430 0.128 
ceoB I35_6448 0.311 
I35_6539 I35_6539 0.026 
I35_6665 I35_6665 ND 
I35_6680 I35_6680 0.107 
I35_7021 I35_7021 0.007 
sfnR I35_7049 0.117 
I35_7211 I35_7211 0.279 
I35_7292 I35_7292 0.248 
I35_7336 I35_7336 0.296 
I35_7338 I35_7338 0.280 
I35_7360 I35_7360 ND 
ilvD I35_7391 0.329 
I35_7411 I35_7411 ND 
I35_7463 I35_7463 0.314 
I35_7529 I35_7529 ND 
I35_7706 I35_7706 0.083 
I35_7738 I35_7738 ND 
I35_7812 I35_7812 0.009 
dhT I35_7854 ND 
I35_7855 I35_7855 0.049 
I35_7856 I35_7856 ND 
 
We also identified 46 genes that were negatively regulated by valazole (Table 6). 
Among these genes, two encode proteins that are directly connected to metal 
Chapter II: Results 
63 
 
homeostasis, namely a zinc uptake regulation protein (I35_2669) and a zinc-
regulated outer membrane receptor (I35_5427). Other genes identified encode 
proteins which rely on metal ions for their enzymatic activity, including the rubredoxin-
type Fe(Cys)4 protein, RubA (I35_2387),  an adenosylcobinamide-phosphate 
guanylyltransferase (I35_2517), which is involved in cobalamin biosynthesis, a 
quinone oxidoreductase (I35_4578), the taurine catabolism dioxygenase TauD 
(I35_4965) and FdnI (I35_4938), the gamma subunit of formate dehydrogenase.  The 
only negatively regulated gene cluster is located on pC3 and spans six genes, which 
encode two proteins from the queuosine biosynthesis pathway (I35_6423; QueD and 
I35_6424) along with a dihydroorotase (I35_6421; pyrC), a carbonic anhydrase 
(I35_6422) an acyl-CoA dehydrogenase (I35_6426) and a putative metal chaperone 
GTPase (I35_6425). Four out of six genes from this gene cluster either use metals in 
their active center or are involved in metal homeostasis. The cluster could either be 
involved in queuosine biosynthesis or deazapurine biosynthesis. 
 
Table 6: Genes with statistically significant increased expression (pval<0.1) above the 
threshold (>3-fold change) in H111 ΔhamD (hamD) compared to H111 wildtype (wt). NA: not 
applicable because read number for wt was 0. 
Name locus_tag fold change hamD vs wt 
cheD I35_0140 5.588 
I35_0178 I35_0178 NA 
I35_1157 I35_1157 NA 
I35_1212 I35_1212 NA 
I35_1679 I35_1679 NA 
rubA I35_2387 NA 
I35_2517 I35_2517 NA 
I35_2669 I35_2669 3.660 
I35_2776 I35_2776 25.078 
I35_3066 I35_3066 8.704 
I35_3237 I35_3237 3.438 
I35_3290 I35_3290 NA 
I35_4099 I35_4099 NA 
I35_4494 I35_4494 6.371 
I35_4532 I35_4532 NA 
I35_4578 I35_4578 NA 
I35_4579 I35_4579 NA 
I35_4691 I35_4691 NA 
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fdnI I35_4938 4.676 
I35_4965 I35_4965 7.580 
xsc I35_5029 NA 
I35_5060 I35_5060 NA 
I35_5364 I35_5364 NA 
I35_5398 I35_5398 NA 
I35_5409 I35_5409 4.071 
I35_5427 I35_5427 11.693 
I35_5616 I35_5616 NA 
I35_5633 I35_5633 NA 
I35_5858 I35_5858 NA 
I35_5863 I35_5863 9.351 
I35_5876 I35_5876 NA 
bscK I35_5886 169.066 
I35_5898 I35_5898 NA 
I35_6340 I35_6340 NA 
pyrC I35_6421 6.091 
I35_6422 I35_6422 12.915 
QueD I35_6423 18.860 
I35_6424 I35_6424 19.414 
I35_6425 I35_6425 29.852 
I35_6426 I35_6426 7.093 
fedB I35_6440 NA 
I35_6659 I35_6659 NA 
I35_7299 I35_7299 3.997 
I35_7638 I35_7638 NA 
I35_7795 I35_7795 NA 
I35_7876 I35_7876 NA 
 
Comparison of the transcriptome of the wild-type with that of the hamD mutant in the 
presence of 100 µM valazole revealed a strong repression of the pyochelin 
biosynthesis cluster by valazole (Tables 7 and 8) while in the genetically 
complemented strain, H111ΔhamD/pBBRhamD, two additional copper metallo 
chaperones (I35_1025 and I35_6107) and two cytochrome oxidases (I35_1026 and 
I35_2071) were found to be repressed (Tables 9 and 10). These genes were not 
differentially regulated in the hamD mutant, suggesting that this effect is likely due to 
elevated levels of valazole and/or fragin in the genetically or chemically 
complemented strains.  
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Table 7: Genes with statistically significant decreased expression (pval<0.1) above the 
threshhold (>3-fold change) in H111 ΔhamD + 100 µM valazole (sig) compared to H111 wt 
(wt). ND: not applicable because read number for sig was 0. 
Name locus tag fold change wt vs sig 
I35_0064 I35_0064 0.006 
I35_0100 I35_0100 ND 
hppD I35_0198 0.304 
paaG I35_0207 0.292 
I35_0378 I35_0378 ND 
I35_0708 I35_0708 ND 
dfrA I35_0948 0.071 
I35_1133 I35_1133 ND 
I35_1147 I35_1147 0.186 
I35_1273 I35_1273 ND 
I35_1420 I35_1420 0.266 
I35_1421 I35_1421 0.199 
cysP I35_1562 0.309 
I35_1669 I35_1669 ND 
I35_1976 I35_1976 0.012 
I35_2183 I35_2183 ND 
cysNC I35_2189 0.070 
kdpA I35_2307 0.326 
gp36 I35_2423 ND 
I35_2487 I35_2487 0.084 
I35_2544 I35_2544 0.330 
I35_3012 I35_3012 0.115 
potG I35_3071 ND 
I35_3177 I35_3177 0.164 
I35_4006 I35_4006 ND 
I35_4014 I35_4014 ND 
I35_4047 I35_4047 ND 
I35_4090 I35_4090 0.291 
I35_4194 I35_4194 ND 
I35_4227 I35_4227 ND 
I35_4350 I35_4350 0.327 
I35_4351 I35_4351 ND 
I35_4374 I35_4374 ND 
I35_4401 I35_4401 0.239 
I35_4438 I35_4438 ND 
I35_4593 I35_4593 0.225 
I35_4681 I35_4681 ND 
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I35_4689 I35_4689 ND 
I35_4841 I35_4841 0.209 
I35_5045 I35_5045 ND 
I35_5066 I35_5066 0.182 
I35_5131 I35_5131 0.007 
I35_5228 I35_5228 ND 
I35_5281 I35_5281 ND 
I35_5464 I35_5464 ND 
I35_5487 I35_5487 ND 
I35_5529 I35_5529 0.226 
I35_5631 I35_5631 0.229 
I35_5733 I35_5733 ND 
I35_5787 I35_5787 ND 
I35_5874 I35_5874 0.214 
I35_5996 I35_5996 0.121 
fptA I35_6116 0.289 
pchI I35_6117 0.197 
pchH I35_6118 0.127 
pchG I35_6119 0.147 
pchF I35_6120 0.162 
pchE I35_6121 0.238 
pchD I35_6123 0.146 
pchC I35_6124 0.297 
pchB I35_6125 0.223 
pchA I35_6126 0.149 
I35_6127 I35_6127 0.222 
I35_6197 I35_6197 0.008 
I35_6265 I35_6265 ND 
I35_6268 I35_6268 0.008 
I35_6316 I35_6316 ND 
I35_6317 I35_6317 0.275 
I35_6332 I35_6332 0.329 
I35_6383 I35_6383 ND 
I35_6430 I35_6430 0.135 
I35_6509 I35_6509 ND 
I35_6514 I35_6514 0.309 
I35_6550 I35_6550 0.258 
I35_6561 I35_6561 ND 
I35_6674 I35_6674 0.021 
I35_6680 I35_6680 0.315 
I35_7124 I35_7124 0.011 
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I35_7190 I35_7190 0.059 
I35_7225 I35_7225 ND 
I35_7275 I35_7275 ND 
I35_7292 I35_7292 0.136 
I35_7320 I35_7320 ND 
I35_7336 I35_7336 0.320 
I35_7338 I35_7338 0.184 
I35_7393 I35_7393 0.074 
I35_7431 I35_7431 ND 
I35_7630 I35_7630 0.177 
I35_7824 I35_7824 ND 
 
Table 8: Genes with statistically significant increased expression (pval<0.1) above the 
threshhold (>3-fold change) in H111 ΔhamD + 100 µM valazole (sig) compared to H111 wt 
(wt). NA: not applicable because read number for wt was 0. 
Name locus tag fold change wt vs sig 
I35_0178 I35_0178 NA 
I35_0350 I35_0350 NA 
hmpA I35_0589 7.883 
I35_1102 I35_1102 4.004 
I35_1157 I35_1157 NA 
I35_1369 I35_1369 NA 
I35_2254 I35_2254 3.512 
cobC I35_2519 6.297 
glcC I35_2816 NA 
I35_3290 I35_3290 NA 
I35_4639 I35_4639 5.020 
I35_4640 I35_4640 5.874 
I35_4641 I35_4641 4.158 
I35_4684 I35_4684 NA 
I35_4695 I35_4695 NA 
I35_4857 I35_4857 4.223 
I35_5060 I35_5060 NA 
I35_5133 I35_5133 NA 
I35_5250 I35_5250 3.203 
rdgC I35_5414 5.793 
I35_5518 I35_5518 267.347 
I35_5817 I35_5817 179.374 
I35_5898 I35_5898 NA 
I35_6161 I35_6161 NA 
I35_6340 I35_6340 NA 
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I35_6397 I35_6397 NA 
ceoA I35_6449 7.803 
I35_6602 I35_6602 4.666 
I35_6603 I35_6603 4.298 
ampC I35_7154 NA 
I35_7324 I35_7324 NA 
I35_7327 I35_7327 NA 
I35_7410 I35_7410 NA 
I35_7413 I35_7413 NA 
I35_7638 I35_7638 NA 
I35_7703 I35_7703 NA 
I35_7715 I35_7715 NA 
I35_7820 I35_7820 10.283 
 
Table 9: Genes with statistically significant decreased expression (pval<0.1) above the 
threshhold (>3-fold change) in H111 ΔhamD pBBRhamD (comp) compared to H111 wt (wt). 
ND: not applicable because read number for comp was 0. 
Name locus tag fold change wt vs comp 
I35_0020 I35_0020 0.052 
I35_0533 I35_0533 0.006 
ureC I35_0767 0.203 
ureB I35_0768 ND 
I35_0775 I35_0775 0.116 
hemN I35_0780 0.108 
I35_0868 I35_0868 0.066 
I35_0869 I35_0869 0.060 
I35_0870 I35_0870 0.003 
rpmF I35_0987 ND 
I35_1025 I35_1025 0.123 
I35_1026 I35_1026 0.291 
gudD I35_1034 0.248 
I35_1077 I35_1077 0.111 
I35_1147 I35_1147 0.226 
I35_1214 I35_1214 0.227 
cysP I35_1562 0.318 
cysT I35_1563 0.306 
fimA I35_1588 0.141 
I35_1589 I35_1589 0.230 
I35_1590 I35_1590 0.153 
I35_1591 I35_1591 0.137 
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I35_1686 I35_1686 ND 
I35_1899 I35_1899 ND 
I35_1976 I35_1976 ND 
aceA I35_2045 0.193 
cyoB I35_2071 0.031 
hutU I35_2172 0.176 
kdpB I35_2306 0.128 
kdpA I35_2307 0.022 
I35_2661 I35_2661 0.092 
I35_2905 I35_2905 0.313 
tlpA I35_2940 0.277 
I35_3276 I35_3276 ND 
fliP I35_3283 0.123 
I35_4048 I35_4048 0.152 
I35_4049 I35_4049 0.246 
I35_4227 I35_4227 ND 
I35_4350 I35_4350 0.133 
I35_4383 I35_4383 ND 
I35_4384 I35_4384 0.012 
I35_4385 I35_4385 0.011 
I35_4386 I35_4386 0.110 
I35_4434 I35_4434 0.095 
I35_4435 I35_4435 0.003 
I35_4591 I35_4591 0.282 
I35_4631 I35_4631 0.235 
I35_4669 I35_4669 ND 
I35_4841 I35_4841 0.323 
I35_4867 I35_4867 0.256 
I35_4868 I35_4868 0.023 
lipA I35_4869 0.149 
I35_5045 I35_5045 ND 
mhbH I35_5121 ND 
I35_5195 I35_5195 ND 
I35_5196 I35_5196 0.092 
I35_5197 I35_5197 0.122 
I35_5198 I35_5198 0.188 
I35_5200 I35_5200 ND 
I35_5255 I35_5255 0.043 
I35_5278 I35_5278 0.014 
I35_5295 I35_5295 0.147 
I35_5296 I35_5296 0.329 
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I35_5372 I35_5372 0.008 
I35_5450 I35_5450 0.230 
I35_5466 I35_5466 ND 
I35_5468 I35_5468 ND 
I35_5537 I35_5537 0.314 
nirB I35_5547 0.050 
I35_5683 I35_5683 0.280 
I35_5776 I35_5776 ND 
I35_5833 I35_5833 ND 
I35_5950 I35_5950 ND 
I35_6104 I35_6104 0.056 
I35_6105 I35_6105 0.030 
I35_6106 I35_6106 0.022 
I35_6107 I35_6107 0.039 
I35_6108 I35_6108 0.020 
I35_6109 I35_6109 0.213 
I35_6110 I35_6110 0.060 
I35_6174 I35_6174 0.020 
I35_6175 I35_6175 0.174 
I35_6317 I35_6317 0.233 
I35_6332 I35_6332 0.163 
metE I35_6384 0.014 
I35_6389 I35_6389 0.080 
I35_6416 I35_6416 ND 
ceoB I35_6448 0.271 
hmuT I35_6524 0.304 
I35_6605 I35_6605 0.027 
I35_6680 I35_6680 0.019 
glcG I35_6700 ND 
I35_7124 I35_7124 ND 
I35_7209 I35_7209 ND 
I35_7289 I35_7289 ND 
I35_7292 I35_7292 0.141 
I35_7354 I35_7354 0.049 
I35_7411 I35_7411 0.028 
I35_7462 I35_7462 ND 
I35_7812 I35_7812 0.005 
I35_7855 I35_7855 ND 
I35_7873 I35_7873 0.011 
bpeB I35_7888 0.048 
I35_0020 I35_0020 0.052 
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I35_0533 I35_0533 0.006 
ureC I35_0767 0.203 
ureB I35_0768 ND 
I35_0775 I35_0775 0.116 
hemN I35_0780 0.108 
I35_0868 I35_0868 0.066 
I35_0869 I35_0869 0.060 
I35_0870 I35_0870 0.003 
rpmF I35_0987 ND 
I35_1025 I35_1025 0.123 
I35_1026 I35_1026 0.291 
gudD I35_1034 0.248 
I35_1077 I35_1077 0.111 
I35_1147 I35_1147 0.226 
I35_1214 I35_1214 0.227 
cysP I35_1562 0.318 
cysT I35_1563 0.306 
fimA I35_1588 0.141 
I35_1589 I35_1589 0.230 
I35_1590 I35_1590 0.153 
I35_1591 I35_1591 0.137 
I35_1686 I35_1686 ND 
I35_1899 I35_1899 ND 
I35_1976 I35_1976 ND 
aceA I35_2045 0.193 
cyoB I35_2071 0.031 
hutU I35_2172 0.176 
kdpB I35_2306 0.128 
kdpA I35_2307 0.022 
I35_2661 I35_2661 0.092 
I35_2905 I35_2905 0.313 
tlpA I35_2940 0.277 
I35_3276 I35_3276 ND 
fliP I35_3283 0.123 
I35_4048 I35_4048 0.152 
I35_4049 I35_4049 0.246 
I35_4227 I35_4227 ND 
I35_4350 I35_4350 0.133 
I35_4383 I35_4383 ND 
I35_4384 I35_4384 0.012 
I35_4385 I35_4385 0.011 
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I35_4386 I35_4386 0.110 
I35_4434 I35_4434 0.095 
I35_4435 I35_4435 0.003 
I35_4591 I35_4591 0.282 
I35_4631 I35_4631 0.235 
I35_4669 I35_4669 ND 
I35_4841 I35_4841 0.323 
I35_4867 I35_4867 0.256 
I35_4868 I35_4868 0.023 
lipA I35_4869 0.149 
I35_5045 I35_5045 ND 
mhbH I35_5121 ND 
I35_5195 I35_5195 ND 
I35_5196 I35_5196 0.092 
I35_5197 I35_5197 0.122 
I35_5198 I35_5198 0.188 
I35_5200 I35_5200 ND 
I35_5255 I35_5255 0.043 
I35_5278 I35_5278 0.014 
I35_5295 I35_5295 0.147 
I35_5296 I35_5296 0.329 
I35_5372 I35_5372 0.008 
I35_5450 I35_5450 0.230 
I35_5466 I35_5466 ND 
I35_5468 I35_5468 ND 
I35_5537 I35_5537 0.314 
nirB I35_5547 0.050 
I35_5683 I35_5683 0.280 
I35_5776 I35_5776 ND 
I35_5833 I35_5833 ND 
I35_5950 I35_5950 ND 
I35_6104 I35_6104 0.056 
I35_6105 I35_6105 0.030 
I35_6106 I35_6106 0.022 
I35_6107 I35_6107 0.039 
I35_6108 I35_6108 0.020 
I35_6109 I35_6109 0.213 
I35_6110 I35_6110 0.060 
I35_6174 I35_6174 0.020 
I35_6175 I35_6175 0.174 
I35_6317 I35_6317 0.233 
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I35_6332 I35_6332 0.163 
metE I35_6384 0.014 
I35_6389 I35_6389 0.080 
I35_6416 I35_6416 ND 
ceoB I35_6448 0.271 
hmuT I35_6524 0.304 
I35_6605 I35_6605 0.027 
I35_6680 I35_6680 0.019 
glcG I35_6700 ND 
I35_7124 I35_7124 ND 
I35_7209 I35_7209 ND 
I35_7289 I35_7289 ND 
I35_7292 I35_7292 0.141 
I35_7354 I35_7354 0.049 
I35_7411 I35_7411 0.028 
I35_7462 I35_7462 ND 
I35_7812 I35_7812 0.005 
I35_7855 I35_7855 ND 
I35_7873 I35_7873 0.011 
bpeB I35_7888 0.048 
 
Table 10: Genes with statistically significant increased expression (pval<0.1) above the 
threshold (>3-fold change) in H111 ΔhamD pBBRhamD (comp) compared to H111 wt (wt). 
NA: not applicable because read number for wt was 0. 
Name locus tag fold change wt vs comp 
I35_0046 I35_0046 NA 
I35_0178 I35_0178 NA 
I35_0349 I35_0349 4.593 
I35_1369 I35_1369 NA 
I35_1520 I35_1520 NA 
lipA I35_1827 5.607 
cobC I35_2519 4.874 
ilvD I35_2532 3.394 
I35_2741 I35_2741 4.721 
phbB I35_2838 3.643 
I35_2840 I35_2840 3.584 
I35_2891 I35_2891 3.341 
I35_2892 I35_2892 3.463 
I35_2893 I35_2893 3.994 
I35_2894 I35_2894 3.204 
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I35_2895 I35_2895 4.339 
I35_3177 I35_3177 3.263 
gspM I35_3297 NA 
I35_4074 I35_4074 3.565 
I35_4099 I35_4099 NA 
I35_4194 I35_4194 5.638 
I35_4198 I35_4198 3.142 
I35_4618 I35_4618 15.119 
I35_4684 I35_4684 NA 
I35_4691 I35_4691 NA 
I35_4730 I35_4730 NA 
I35_5364 I35_5364 NA 
I35_5529 I35_5529 6.207 
I35_5530 I35_5530 4.371 
I35_5875 I35_5875 4.205 
I35_5876 I35_5876 NA 
I35_5878 I35_5878 5.573 
I35_5879 I35_5879 6.281 
I35_5880 I35_5880 4.442 
bscL I35_5885 NA 
bscK I35_5886 766.641 
I35_5888 I35_5888 8.570 
bscD I35_5890 5.757 
bscC I35_5891 7.500 
I35_6161 I35_6161 NA 
I35_6180 I35_6180 3.755 
rhlC I35_6229 10.413 
rhlA I35_6233 3.312 
pqqB I35_6259 3.875 
fedB I35_6440 NA 
I35_6655 I35_6655 6.655 
I35_6659 I35_6659 NA 
I35_7574 I35_7574 3.018 
I35_7590 I35_7590 NA 
I35_7595 I35_7595 3.280 
I35_7603 I35_7603 9.031 
I35_7604 I35_7604 3.838 
I35_7610 I35_7610 3.411 
I35_7620 I35_7620 6.715 
I35_7638 I35_7638 NA 
I35_7703 I35_7703 NA 
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3.5 Regulatory elements in the ham promoter region 
Ryan and colleagues [55] mapped the CepR2 binding site in the bidirectional 
promoter region of the ham cluster. Additional prediction of putative promoter regions 
with the BPROM online tool revealed three -10 and -35 boxes which could act as 
promoter sites for the expression of the hamABCDE operon and placed one of the 
putative promoters (P2) next to the CepR2 binding site (Figure 21A). In addition to 
the previously constructed transcriptional fusion of the full hamA promoter region to 
lacZ (PhamA-lacZ), which contains all three putative promoters (P1 – P3) along with 
the CepR2 binding site, three truncated hamA promoter fragments were constructed. 
PhamA122-lacZ only contained the -10 box of P1, PhamA222-lacZ contained the full 
P1 promoter, and PhamA281-lacZ contained the P1 promoter and the CepR2 binding 
site. The three truncated transcriptional hamA promoter fusions were introduced into 
H111 and H111 ΔhamD and β-galactosidase activities were measured. No promoter 
activity was present in any of the four tested constructs in the hamD mutant 
background (Figure 21B). In the wild-type background, PhamA122-lacZ showed no 
activity. This was expected, as the construct only contained the -10 box of the first 
putative promoter. The activity of the PhamA281-lacZ construct was comparable to 
the full length construct. The highest activity was observed in the PhamA222-lacZ 
construct (Figure 21B). This implies that the P1 promoter is both necessary and 
sufficient to drive expression of the hamABCDE operon. In addition, an element 
which negatively affects the hamA promoter activity seems to be present in the 
region spanning the -222 to -281 region, which contains the CepR2 binding site. This 
is surprising, as CepR2 was clearly necessary for hamA promoter activity. Although 
no other regulatory elements were predicted for the region between position -222 and 
-281, it might be possible that a so far unknown regulatory element in this region is 
responsible for the observed difference of hamA promoter activities.   
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Figure 21: The presence of the CepR2 binding box is not necessary for the hamA promoter 
activity. A) Schematic depiction of the truncated hamA promoter fusions. P1, P2, P3: putative 
promoter regions (-10 box and -35 box) ; CepR2: CepR2 binding box ; 5’UTR: 5’ untranslated 
region. B) The hamA promoter activity derived from the full promoter region (PhamA-lacZ) 
and the three truncated constructs (PhamA122-lacZ, PhamA222-lacZ and PhamA281-lacZ) 
was tested in the wild type (H111 wt) and the hamD mutant (H111 ΔhamD) background. No 
promoter activity was observed in the H111 ΔhamD background. No promoter activity was 
present in the shortest construct (PhamA122-lacZ). The highest activity was observed in 
thePhamA222-lacZ construct followed by PhamA-lacZ and PhamA281-lacZ. Results are 
presented as means ± SD from three independent biological replicates carried out in 
technical triplactes. 
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3.6 Iron positively regulates expression of the ham cluster 
We have shown that iron reduces antifungal activity by directly interfering with the 
antifungal activity of fragin in vitro (Figure 14). Nevertheless, this does not exclude 
the possibility that iron might also influence ham gene transcription. This would not 
be surprising, as production of other metal chelating molecules is tightly controlled by 
iron. Siderophores like pyochelin and ornibactin, for example, are downregulated in 
the presence of free iron. 
To examine if the ham genes are also downregulated in the presence of high iron 
concentrations, the hamA promoter activity was measured in the presence of 
increasing amounts of iron in the growth medium. An approximately 20-fold increase 
of promoter activity was seen when the cultures were grown with 1 µM iron compared 
to 100 nM iron. This trend was also observed in a culture grown with 10 µM iron, 
which resulted in a 10-fold higher promoter activity compared to 1 µM iron (Figure 
22). At the same time, the cultures reached similar OD600 values, independent of the 
iron concentration in the medium, demonstrating that the observed difference in 
promoter activities is not due to differences in growth.  
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4 Discussion 
In this study, we identified an NPRS-like gene cluster in B. cenocepacia H111, the 
so-called ham cluster, which directs the synthesis of two distinct molecules, the 
antifungal molecule fragin and a novel signal molecule which we have named 
valazole.  
The initial ham cluster-derived molecule identified in this study was the antifungal 
molecule fragin, which was first isolated in 1967 in a screen for novel plant growth 
inhibitors [218]. Fragin was reported to be synthesized by Pseudomonas fragi, but 
subsequent studies on P. fragi were unable to confirm the production of fragin [222]. 
Currently there is one whole shotgun sequence of P. fragi B25 deposited at GenBank 
(accession number NZ_AHZX01000000). Thorough investigation of the eleven 
scaffolds (NZ_JH604622.1 – NZ_JH604632.1) showed that no gene cluster with 
similarity to the ham cluster is present in the sequenced P. fragi genome. Also, there 
are no sequenced bacterial strains besides B. cenocepacia deposited at public 
databases that harbor both ham operons (Figure 2), which are essential for fragin 
biosynthesis. Based on this, the strain from which fragin was originally isolated might 
have been a B. cenocepacia strain, misidentified as P. fragi.  
 
4.1 Antimicrobial activity of fragin 
The most outstanding feature of fragin and valazole is their nitrosohydroxylamine 
group, also described as an N-hydroxy-N-nitrosamine group in the literature [220]. 
Molecules bearing this functional group are rarely found in nature, but all of them 
show potent biological activities, including antifungal, antibacterial, antiviral and 
antitumor activities (reviewed in [220, 221]), which makes this group of molecules an 
interesting source for drug development.  
The first described natural product with a nitrosohydroxylamine group was alanosine, 
isolated in 1966 from Streptomyces alanosinicus [223]. Alanosine was shown to have 
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antibiotic activity against Candida albicans, Mycobacterium marinum and 
Saccharomyces cerevisiae [224]. Besides its antibiotic activity, it also exhibited 
antiviral properties and had immunosuppressive effects in several animal models 
[225, 226]. Most notably, alanosine was investigated in clinical trials as a potential 
chemotherapy drug due to its antitumor activity [227]. In 1967, the antifungal 
molecule fragin, the biosynthesis of which is investigated in this study, was isolated in 
a screen for novel plant growth inhibitors. This compound was shown to inhibit the 
growth of Gram-positive and Gram-negative bacteria, algae, yeast and fungi [218]. 
The reported activity of fragin against the Gram-negative bacterium E.coli is of 
particular interest for this study, as no growth inhibition of Gram-negative bacteria, 
including two different E. coli strains, was observed in the present study.  In the study 
of Tamura and Murayama [218] the amount of fragin reported to inhibit the growth of 
E. coli was 100 ppm, which equates to 100 µg/ml. In our study, we used a maximum 
of 40 µg fragin spotted on filter discs to test antibacterial activity (Figures 10C and 
10D show the results with 20 µg fragin). To clearly determine if fragin can inhibit 
Gram-negative bacteria, additional disc diffusion assays with higher amounts of 
fragin would be required.  
While the precise mode of action is not known for any naturally occurring 
nitrosohydroxylamine, alanosine has been shown to interfere with aspartate utilizing 
enzymes of the purine and pyrimidine biosynthesis pathway, by serving as a 
structural analog of carboxylic acid [228]. In addition, alanosine was found to chelate 
copper and zinc [229] and the synthetic nitrosohydroxylamine cupferron is commonly 
used as a metal chelator [230-233]. Interestingly, mushroom tyrosinase, which uses 
copper in its active center [234], is inhibited by dopastin and cupferron [235-237]. 
Dopamine beta-hydroxylase, another copper dependent enzyme [238] is also 
inhibited by dopastin [239], while 5-lipoxygenase, which has iron in its active center 
[240], is inhibited by nitrosoxacins A, B and C [241]. The presence of the 
nitrosohydroxylamine group in the fragin structure, in addition to the observed loss of 
antifungal activity in the presence of iron, suggests that fragin, like other 
nitrosohydroxylamines might inhibit the growth of other microbes, either by metal 
chelation or by inactivating enzymes that rely on metals for their activity.  
Several fungal enzymes, including superoxide dismutase (SOD) and cytochrome C 
oxidase are copper-dependent [242]. SODs protect the fungal cell against oxidative 
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stress, especially against the oxidative burst of phagocytic cells [243]. Cytochrome C 
oxidase is the terminal enzyme in the mitochondrial respiratory chain [243]. 
Importantly, iron uptake in fungi is partially depend on copper via a high-affinity Cu-
dependent iron transporter [244]. Therefore copper chelation by fragin could 
potentially disrupt the respiratory chain and leave the fungus more susceptible to 
oxidative stress, while at the same time it could also restrict iron uptake.  
 
4.2 Gene regulation by the novel signaling molecule valazole 
In addition to the identification of fragin as the major antifungal compound of B. 
cenocepacia H111, we also identified valazole, a second nitrosohydroxylamine 
compound, which is synthesized by a sub-set of the ham genes. Valazole shows 
remarkable structural similarity to fragin, only lacking an amino group and the acyl-
chain which is attached to the valine core. Valazole acts as a signaling molecule in a 
positive feedback loop, driving its own expression as well as that of fragin (Figures 
20A and 20B, Tables 5 and 6). Interestingly, several studies in P. syringae pv. 
syringae UMAF0158 and P. entomophila have identified a gene cluster responsible 
for the production of a putative extracellular signaling molecule. The identified gene 
clusters, mgo in P. syringae pv. syringae UMAF0158 and pvf in P. entomophila show 
striking similarity to the hamABCDE operon, only lacking a hamB homolog , which is 
not required for valazole biosynthesis in B. cenocepacia H111. The mgo-derived 
signaling molecule was shown to regulate expression of the biosynthetic genes for 
mangotoxin production in P. syringae pv. syringae UMAF0158 [217], while pvf was 
shown to be involved in P. entomophila virulence in a drosophila model [216]. 
Examination of the A domain substrate binding pockets of PvfC, MgoC and HamD 
showed that PvfC and HamD share the same amino acid sequence (DALFVGIV), 
while PvfC has a different binding pocket sequence (DSIFMGLV) (Table 3). 
Nevertheless, prediction of the amino acid substrates using NRPSpredictor 2 and 
NRPSsp online tools suggested that all three enzymes incorporate the same amino 
acid as a building block for the signaling molecule. Taken together, valazole might be 
the prototype of a new class of signaling molecules which are produced by members 
of the genera Burkholderia, Pseudomonas and Pandorae (Figure 4). Valazole 
controls expression of the transcriptional regulators CepS and CepR2, which in turn 
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regulate expression of the ham gene cluster. Interestingly, a tripartite multidrug 
resistance system located next to the ham cluster is also regulated by valazole, 
indicating a putative role as a fragin and/or valazole transporter. Further 
investigations are required to elucidate the role, if any, of this system in fragin or 
valazole transport. The most unexpected valazole-regulated functions identified by 
global RNA-Seq analysis were those with a putative role in 3-methyl-2-oxobutanoate 
metabolism (Table 5). 3-methyl-2-oxobutanoate is the intermediate metabolite at the 
branching point of the valine and leucine biosynthesis pathways. Based on the RNA-
Seq data, valazole specifically upregulated six genes (I35_2532, I35_2881, 
I35_4185, I35_4642, I35_7391 and I35_4373) involved in the metabolism of 3-
methyl-2-oxobutanoate. Two of these genes encode IlvD homologs, which can 
potentially shunt 3-methyl-2-oxobutanoate away from valine biosynthesis. Restricting 
valine biosynthesis might be a mechanism to regulate fragin and valazole 
biosynthesis.  
At present it is not known whether valazole binds to a specific receptor, but CepR2 
and CepS are encoded by genes adjacent to the ham cluster and thus are good 
candidates. CepR2 is a solo LuxR-type regulator. These have been shown to not 
only bind AHL molecules but also pyrones and dialkylresorcinols [52, 53]. Sequence 
alignments of LuxR-type regulators have shown that six amino acid residues in the 
signal binding domain (SBD) are conserved in 95 % of LuxR proteins and these 
residues are involved in binding their cognate AHL molecules [245]. As these amino 
acid residues (WYDPG) are fully conserved in CepR2, and AHL binding has been 
experimentally proven for CepR2 from B. cenocepacia K56-2 [55], it is unlikely that 
CepR2 is a valazole receptor. Therefore, the AraC-type regulator CepS remains the 
best candidate valazole receptor and additional work will be required to test this 
possibility.  
Valazole could also alter transcription of the ham genes by binding to a riboswitch. 
Riboswitches are metabolite sensing RNA elements found in 5’UTR regions, which 
can alter the transcription of their respective mRNAs. They recognize a broad range 
of metabolites including amino acids, vitamin cofactors, amino sugars, metal ions and 
secondary messengers (reviewed in [246]). Therefore the unusually long 5’UTR of 
the hamABCDE operon might contain a riboswitch which controls ham gene 
expression. Nevertheless, thorough investigation of the 5’UTR did not identify any 
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putative riboswitches in this area. In addition, both the hamABCDE and hamFG 
operons, are regulated by valazole, and therefore the presence of a riboswitch in the 
5’UTR of hamABCDE would not explain the observed regulation of the hamFG 
operon. As CepR2 and CepS are both necessary for full activity of both ham operons 
and both regulators were positively regulated by valazole in our global RNA-seq 
analysis, valazole might not directly regulate the expression of the ham genes, but 
rather drive the expression of CepR2 and CepS.  
 
4.3 Biological activity of valazole beyond bacterial signaling 
It is also important to mention that our data supports a role of valazole beyond its 
function as a signaling molecule. One clear indication is the amount of valazole which 
is necessary to induce ham promoter activity to a level similar to that of the wild-type 
strain. The required valazole concentration of 50 µM is much higher than that 
determined for dedicated signaling molecules like AHLs or BDSF, which are in the 
range of 5 nM to 5 µM. Further evidence that valazole is a multifunctional molecule is 
the finding that it affects transcription of genes involved in metal 
transport/homeostasis as well as those encoding metal dependent enzymes. Several 
of these genes are not associated with iron, but rather with copper, which suggests 
that fragin and valazole affect gene transcription by copper chelation. The signaling 
function of valazole together with the metal chelating ability of both fragin and 
valazole is reminiscent of the quinolone quorum sensing system of Pseudomonas. 
The Pseudomonas aeruginosa QS signal molecule known as  Pseudomonas 
quinolone signal (PQS) and its immediate precursor 2-heptyl-4-quinolone (HHQ) are 
both employed as signaling molecules [66, 71] that drive expression of their own 
biosynthesis genes via the regulator PqsR. In addition, PQS was shown to regulate 
several virulence factors, including pyocyanin and the siderophores pyochelin and 
pyoverdin [73]. PQS was also shown to chelate iron and to possibly function as an 
iron trap at the cell surface. This is thought to create a shortage of free iron, leading 
to an up-regulation of pyochelin and pyoverdin production. As both siderophores 
have a higher affinity for iron than PQS, ferric iron can be transferred from 
membrane-associated PQS to either of the two siderophores [71]. Here it is of special 
interest to mention, that the complementation of a fragin and valazole negative strain 
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with synthetic valazole resulted in a strong down-regulation of the pyochelin 
biosynthesis cluster (Table 10). This indicates that valazole might be used to supply 
the cell with iron and possibly other metals (e.g. copper), either directly or by 
interacting with pyochelin or ornibactin.  
 
4.4 The influence of iron on antifungal activity and the ham 
cluster 
The addition of excess iron to agar plates resulted in the development of a yellow 
colony phenotype which was independent of the two siderophores pyochelin and 
ornibactin, but was directly connected to the presence and expression of the ham 
gene cluster. Mutants bearing single gene deletions of several ham genes as well as 
of the positive ham cluster regulators CepR2 and CepS did not develop the yellow 
colony phenotype and remained white, while deletion of an AraC regulator 
(I35_4197) encoded immediately downstream of the hamABCDE operon, resulted in 
a bright yellow colony phenotype, which was accompanied by increased antifungal 
activity, implying that it is a positive regulator of the ham cluster. Given that the hamF 
mutant does not produce fragin, but is still capable of valazole biosynthesis, the 
yellow colony phenotype seems to be dependent on fragin but not valazole. As fragin 
and valazole have the same nitrosohydroxylamine functional group, both molecules 
should be able to bind metals. Based on the determined structures of the two 
compounds, valazole is more likely to freely diffuse in and out of the cell, while the 
fatty acid tail of fragin might prevent it from freely diffusing through the cell wall. 
Therefore, the yellow colony phenotype might be explained by iron chelation by 
fragin and subsequent precipitation of the fragin-iron complex in the culture 
supernatant, or its association with the cell envelope, in a similar manner to that 
reported for PQS, as discussed above. 
In agreement with the proposed function of CepR2 as negative regulator of the ham 
cluster in strain K56-2 and positive regulator in strain H111, the K56-2 wild type strain 
did not show a yellow colony phenotype, while the CepR2 mutant did. This not only 
supports the idea of diametrically opposed roles of CepR2 in the two B. cenocepacia 
strains, but also indicates involvement of the ham cluster in formation of the yellow 
colony phenotype.  
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Further support comes from the successful exploitation of the yellow colony 
phenotype as a screening tool for genes involved in antifungal activity and ham 
cluster regulation. Mutants in the ham cluster, as well as several regulators some of 
which were not known to regulate antifungal activity at the time of the transposon 
screen were identified based on the yellow colony phenotype and all of them have 
been confirmed to be involved in antifungal activity or ham gene regulation.  
Another important mechanism by which iron influences antifungal activity is through 
the siderophores pyochelin and ornibactin. While mutations in each of the 
siderophore biosynthesis genes had little effect on antifungal activity, a very strong 
reduction was observed in a strain that is deficient in both pyochelin and ornibactin 
biosynthesis. As high iron concentrations lead to lowered expression of siderophores, 
the observed loss of antifungal activity is possibly connected to a down-regulation of 
siderophore expression.  
 
4.5 Positive regulation of the ham genes by iron 
Antifungal activity was reduced in the presence of excess iron in the medium. In 
contrast to this, expression of the ham genes was activated by iron. Although this 
seems counterintuitive, we have established that iron lowers the activity of extracted 
fragin in vitro (Figure 15). Hence, elevated fragin production in the presence of high 
amounts of iron may allow the cell to reserve parts of the available iron for later use, 
when iron becomes scarce in the environment. This strategy might give B. 
cenocepacia an advantage over other microbes competing for available iron. The 
same is most likely true for copper. Fragin as well as valazole bind copper in vitro 
(personal communication, Christophe Daeppen) and therefore it is possible, that both 
molecules might serve as copper storage system for the cell, either intra- or 
extracellularly. Therefore it would also be very interesting to see, if copper can 
stimulate ham gene expression, as we have shown for iron.  
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4.6 Fragin and valazole biosynthesis 
Despite the fact that nitrosohydroxylamines have great potential for drug 
development, with alanosine under investigation in clinical trials as a potential 
chemotherapeutic drug [247], no information is available on the biosynthesis of this 
functional group. This is in part owed to the fact that no genomic sequence data is 
available for microbes which have been shown to produce nitrosohydroxylamine 
derivatives. Therefore this is the first report linking a molecule with a 
nitrosohydroxylamine group to its biosynthetic gene cluster. 
The data obtained for the structural elucidation of fragin showed that the naturally 
occurring enantiomer is D-fragin. Feeding studies with C13- and N15-labeled L-leucine 
and L-valine showed the highest incorporation rate was for C13-labeled L-valine into 
fragin (Table 4) Accordingly, L-valine is the most likely substrate of the HamD A 
domain.  
Although the observed incorporation rate of C13-labeled L-valine was not much higher 
than those of the other three isotopically labeled amino acids (10 % vs 4 – 5 %), one 
must bear in mind that for L-valine all five carbon atoms were C13-labeled and 
therefore the observed mass shift (+5 m/z) is very specific and cannot be explained 
by any mechanism other than incorporation. The C13-labeled L-leucine, as well as the 
N15-labeled L-leucine and L-valine, were only labeled on a single carbon or nitrogen 
atom. Therefore it is possible that the labeled residues entered the bacterial 
metabolism via leucine or valine degradation and the observed mass shifts resultfrom 
the incorporation of C13 or N15 atoms and not leucine or valine. This hypothesis is 
supported by the fact that feeding studies with the N15-labeled amino acids also 
showed incorporation of N15 into the siderophore pyochelin (personal communication 
by Simon Sieber, unpublished data), which does not contain a valine or a leucine 
residue. Together with the relatively low incorporation rate of < 5 %, it is most likely 
that L-leucine is not specifically incorporated into fragin.  
Many NRPS-derived secondary metabolites have non-proteinogenic amino acids 
incorporated into their structures. Nearly 500 non-proteinogenic amino acids are 
known to date and they are synthesized either from pre-existing proteinogenic amino 
acids or by de novo biosynthesis [248]. D-amino acids are synthesized from their L 
enantiomers by racemases or epimerases, which are part of their respective NRPS 
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megaenzymes [171, 184]. As no epimerase or racemase domain is encoded within 
the ham locus, the enzymes required for epimerization of L-valine to D-fragin remain 
to be identified. While isolated fragin is exclusively in the D-configuration, valazole 
was found to be a racemic mixture (personal communication by Christophe Daeppen, 
unpublished results). This suggests that epimerization occurs at the branching point 
of the valazole and fragin biosynthesis pathways. A more thorough discussion of the 
possible epimerization reaction will be provided in the biosynthesis section later in 
this chapter.  
 
4.7 Biosynthesis of the bioactive nitrosohydroxylamine group 
Biosynthesis of the nitrosohydroxylamine group of valazole and fragin requires the 
modification of the native valine amino group. This might be accomplished by a post-
assembly or an on-line tailoring reaction. The latter include alkylation, hydroxylation 
and heterocyclization reactions as well as the synthesis of various ring systems [182]. 
To date, no nitrosylation reaction has been describedas an on-line tailoring reaction. 
Despite the lack of literature on this subject, there are several reasons why the 
formation of the nitrosohydroxylamine group of fragin and valazole is probably an on-
line tailoring reaction. We were unable to identify intermediates of fragin or valazole 
biosynthesis in supernatants of any of the ham gene mutants (personal 
communication by Simon Sieber, unpublished data). If fragin or valazole had 
undergone post-assembly tailoring, one would expect to find intermediates of either 
of the two molecules lacking the nitrosohydroxylamine group. Furthermore, the fatty 
acid chain of fragin is attached to the valine moiety via an amino group most likely 
introduced by the putative amino transferase HamG. So far, all natural products 
which are acylated by a starter condensation domain have their acyl chain attached 
to the native amino group of the first amino acid in the assembly line. If the native 
valine amino group were still present when fragin was released from HamD, acylation 
could theoretically take place on this amino group and a corresponding molecule 
should be detectable in the organic solvent extracts. Therefore, it is most likely that 
the nitrosohydroxylamine group is the result of on-line tailoring reactions. 
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4.8 Acylation of the fragin precursor 
Another unique feature of the fragin structure, as briefly mentioned above, is the 
localization of its acyl chain. Acylation by starter condensation domains has only 
been reportedto take place at the native amino group of the first amino acid in the 
peptide chain [159, 249]. In this respect, the ham cluster clearly differs from other 
NRPS assembly lines, as its starter condensation domain is not the first module on 
the NRPS enzyme (HamD), but is located on a separate protein (HamF). 
Furthermore, the ham cluster does not synthesize a peptide, but rather synthesizes a 
single modified amino acid (valazole) and its acylated derivative (fragin). The unique 
positioning of the acyl chain on the final molecule (fragin) is either a pre-requisite for 
the formation of the nitrosohydroxylamine group or a consequence thereof.  
 
4.9 A unified model for fragin and valazole biosynthesis 
The structural information obtained for fragin and valazole (Figures 10A and 19C,) 
along with the in silico predicted enzymatic function of the ham cluster encoded 
proteins (Figure 3B) allows us topropose a model for the biosynthesis of fragin and 
valazole (Figure 23). As already discussed above, the nitrosohydroxylamine group is 
most likely synthesized by on-line tailoring of the valine amino group.  Formation of 
the nitrosohydroxylamine group probably involves HamC. Owing to the high 
conservation of residues responsible for substrate specificity between HamC and 
PsAAO (Figure 3C), it is likely that HamC oxidizes an aromatic amine to an aryl nitro 
compound as demonstrated for PsAAO [214]. The resulting aryl nitro compound 
might serve as an NO2 donor for the formation of the nitrosohydroxylamine group. A 
similar mechanism was recently proposed for diazo group formation in cremeomycin 
biosynthesis [250]. Unpublished results obtained by the group of Prof. Karl 
Gademann have demonstrated that a synthetic hydroxyl amine derivative of fragin 
reacts spontaneously with NaNO2 to give rise to fragin (personal communication by 
Simon Sieber, unpublished data), which is in good agreement with an aryl nitro 
compound as NO2 donor. HamA and HamE are essential for both fragin and valazole 
biosynthesis and therefore they are likely to be involved in the formation of the 
nitrosohydroxylamine group. The branching point of valazole and fragin biosynthesis 
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seems to be the reductive release of the precursor from HamD. As has been 
demonstrated for myxochelin A and B biosynthesis, R domain catalyzed release of 
NRPS-bound amino acids proceeds in two 2-electron reduction steps, which can be 
competitively transaminated during the second reduction step [180]. The first R 
domain catalyzed 2-electron reduction results in an aldehyde intermediate, which can 
then undergo a second R domain catalyzed 2-electron reduction to yield valazole, or 
alternatively can be transaminated by HamG. The resulting amino derivative could 
then be acylated by HamF to yield fragin (Figure 7). While we have shown that L-
valine is incorporated into fragin, the naturally occurring stereoisomer of fragin is D-
fragin and the isolated valazole was racemic (D-valazole and L-valazole). As no 
epimerases or racemases are encoded by the ham genes, formation of the fragin and 
valazole D-enantiomers seem to derive from another tailoring reaction. The fact that 
fragin is only found as the D-enantiomer could be explained by enantioselectivity of 
the transamination (HamG) reaction or the acylation reaction (HamF). In fact, it has 
been shown that the binding pockets of C domains are enantioselective [251]. In this 
scenario, the biosynthetic precursor at the branching point of valazole and fragin 
biosynthesis is likely to be racemic, but only the D-enantiomer can be further 
processed to fragin due to the enantioselectivity of HamF. Such a system would also 
assure the production of enough valazole to drive the expression of the ham genes.  
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Figure 21 : Proposed model for fragin and valazole biosynthesis.  
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4.10  Regulation of the ham cluster by CepR2 and CepS 
CepR2 is essential for antifungal activity of B. cenocepacia H111 (Figure 7A). In a 
recent paper, Ryan and colleagues investigated the regulatory role of the solo LuxR-
type regulator CepR2 and the AraC-type regulator CepS in the regulation of the ham 
gene cluster in B. cenocepacia K56-2. In contrast to the findings of Mallott and 
colleagues  [54], they showed that CepR2 can bind AHLs and is a negative regulator 
of ham gene expression. They also showed that CepS acts as a positive regulator of 
the ham genes. In their regulatory model, the DNA binding sites of CepR2 and CepS 
in the ham promoter region overlap. Apo-CepR2 binds to the promoter region of the 
ham genes, thereby blocking access for the positive regulator CepS. When QS is 
triggered, CepR2 binds AHLs, and is released from its binding site allowing CepS to 
bind and induce transcription of the ham genes. As we showed that the ham cluster 
is responsible for the antifungal activity of B. cenocepacia H111 and that a cepR2 
mutant is completely devoid of antifungal activity, this model is not valid for strain 
H111. Mutation of CepR2 in strain K56-2 lead to an increase in antifungal activity, 
which is in good agreement with CepR2 acting as a negative regulator of ham gene 
expression. Hence, CepR2 acts as a negative regulator of ham gene expression in 
K56-2, while it is a positive regulator of ham gene expression in strain H111. As there 
is only one nucleotide difference between the predicted CepR2 binding site of K56-2 
and H111, it is not clear how CepR2 can have a diametrically opposite regulatory 
function in the two B. cenocepacia strains. Nevertheless, the ham-dependent 
development of a yellow colony phenotype on agar plates supplemented with high 
amounts of iron supports the different regulatory roles of CepR2 in K56-2 and H111 
(Figure 13). The promoter activity of the hamABCDE operon in H111 was found to be 
clearly downregulated in an H111 cepR2 mutant, again supporting its role as a 
positive regulator of the ham genes in this strain.   
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5 Future prospects 
In this study, we identified an NRPS-like gene cluster which synthesizes two distinct 
molecules, fragin and valazole, which are involved in microbial antagonism and cell-
cell communication. 
 
5.1 Molecular mechanisms of fragin and valazole biosynthesis 
As this is the first study which links a biosynthesis gene cluster to the production of a 
nitrosohydroxylamine molecule, it lays the ground for detailed studies on the 
biosynthesis of nitrosohydroxylamines. A recent study has shown that diazo group 
formation in cremeomycin biosynthesis is most likely accomplished by a spontaneous 
reaction of nitrous acid with a cremeomycin precursor [250]. Given the fact, that the 
two HamC homologues AurF and PsAAO both have aryl amines as substrates, it is 
likely that HamC does not have a fragin or valazole precursor as substrate, but rather 
an aryl amine compound. In this model the nitrosohydroxylamine group is formed 
spontaneously with the help of an NO donor, which is synthesized by HamC. In vitro 
enzyme assays of purified HamC will show whether nitro aryl compounds can be 
synthesized by HamC. Further studies will then be required to show whether these 
molecules are suitable NO donors for spontaneous nitrosohydroxylamine formation.  
 
5.2 The role of fragin and valazole in copper homeostasis 
Nitrosohydroxylamines are well known for their ability to chelate copper and our 
transcriptomics data suggests that valazole regulates several genes which use 
copper in their active center or are involved in copper homeostasis. It will be of great 
interest to further explore the role of fragin and valazole in copper homeostasis. 
Transcriptomics of the B. cenocepacia H111 wild type and its hamF (fragin negative, 
valazole positive) and hamD (fragin negative, valazole negative) mutant derivatives 
grown in the presence of different copper concentrations will help to clarify the 
importance of fragin and valazole in copper homeostasis.  
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5.3 Antimicrobial activity of fragin 
It will also be important to unravel the molecular mechanism of the antifungal activity 
of fragin. As discussed before, it is very likely that fragin restricts competing 
organisms for iron or copper or directly interferes with essential enzymes which rely 
on metals for their enzymatic functions. The cytochrom C oxidase for example is 
located in the mitochondrial membrane while fungal SODs were shown to be located 
within the cell, but have also been found associated with the cell membrane and in 
the supernatant [242, 243]. In this context it will be important to investigate if fragin 
exerts its activity within the target cell or in the extracellular environment. 
 
5.4 Gene regulation by valazole 
Currently it is not known how valazole regulates gene expression in B. cenocepacia 
H111. Valazole might either bind to a riboswitch or to a specific receptor. As no 
putative riboswitches could be predicted in the ham promoter region, gene regulation 
by a riboswitch seems to be very unlikely. We have identified several receptors which 
are involved in the regulation of the ham genes. One of them, CepR2, was shown to 
bind AHLs [55] and is therefore not a promising candidate. In contrast, it is not known 
which molecules are bound by the AraC-type regulator CepS, making it the most 
promising valazole receptor candidate. Promoter activity studies in a heterologues 
host, with CepS expressed from a plasmid and external addition of synthetic valazole 
would be a possible strategy to clarify the possible role of CepS as valazole receptor.  
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Chapter IV: Material and Methods 
 
6 Material and Methods 
6.1 Bacterial strains, plasmids and growth conditions 
Strains and plasmids used in this study are listed in Table 11. Primers used in this 
study are listed in Table 12. The model strains used in this study were Burkholderia 
cenocepacia H111, a cystic fibrosis isolate from Germany [43] and B. cenocepacia 
K56-2, a cystic fibrosis isolate from Canada [252]. Both strains were routinely grown 
at 37°C in Luria-Bertani medium (BDTmDifco, USA). For extraction of fragin and/or 
valazole, as well as promoter activity measurements, strains were grown in ABG 
minimal medium. Yeast extract (0.005 %) was routinely added to boost growth, 
except when the effect of iron on the activity of the ham promoter was tested.  E. coli 
strains were grown in LB medium at 37 °C. When required, media were 
supplemented with antibiotics at the following concentrations: Kanamycin (Km) at 100 
µg/ml, gentamycin (Gm) at 20 µg/ml, trimethoprim (Tp) at 25 µg/ml, chloramphenicol 
(Cm) 20 µg/ml. Antibiotics resuspended in water were filter sterilised (0.44 µm). All 
media were sterilized by autclavation unless stated otherwise. 
 
ABG minimal medium 
component A (A-10x) 
16 g  (NH4)2SO4 
48 g  Na2HPO4 
24 g  KH2PO4 
24 g  NaCl 
dH2O  to a final volume of 800 ml  
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component B 
2 ml  1 M MgCl2 x 6 H2O 
0.2 ml  0.5 M CaCl2 x 2 H2O 
0.3 ml  0.01 M FeCl3 x 6 H2O 
dH2O  to a final volume of 800 ml   
 
component G (carbon source) 
20 % glycerol v/v in dH2O 
 
ABG: 
800 ml component B 
100 ml component A 
100 ml component G 
 
 
Feeding studies with isotopically labeled amino acids 
Bacterial strains were grown in ABG minimal medium at 37 °C with agitation (220 
rpm). Isotopically labeled amino acids, L-leucine-2-13C, L-leucine-15N, L-valine-15N 
(Sigma-Aldrich, Switzerland) and L-valine-13C5 (Cambridge Isotope Laboratories, 
USA) were added to 1 mM final concentration after 24 and 48 hours of incubation. 
After 72 hours incubation, fragin extraction was performed as described in the 
‘Extraction of fragin and valazole’ section. Subsequent ESI-MS analysis to determine 
the incorporation rate of isotopically labeled amino acids into fragin was carried out 
by Simon Sieber from the Group of Prof. Karl Gademann, University of Basel and 
University of Zurich) the mass spectrometry service of the University of Zurich. 
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6.2 Molecular Methods 
Preparation of electrocompetent cells 
E. coli was grown at 37 °C with agitation (220 rpm) in LB broth to exponential growth 
phase. The cells were harvested by centrifugation and washed with 1 volume of ice 
cold 10 % glycerol. After two more washes with 0.5 and 0.2 volumes of ice cold 10 % 
glycerol, the cells were centrifuged and the resulting cell pellet was resuspended in 1 
ml 10 % ice cold glycerol, aliquoted and stored at – 80 °C.  
 
Electroporation of electrocompetent E. coli 
7 µl of the ligation reaction mix was incubated with 70 µl electrocompetent E. coli 
cells for 10 minutes on ice. The mixture was subsequently transferred to 
electroporation cuvettes (BIO-RAD, Gene Pulser Cuvette, 0.2 cm) chilled on ice. The 
cells were subsequently electroporated (25 µF; 200 Ohm ; 2,5 kV) using a BIO-RAD 
GenePulser. Immediately after electroporation, the cells were mixed with warm SOC 
medium [253], incubated with shaking at 37 °C for 1 hour and plated on LB agar 
plates containing the appropriate antibiotic for the selection of positive clones. 
Successful electroporation was confirmed by PCR. 
 
Plasmid transfer 
Plasmids were transferred from E. coli strains to B. cenocepacia strains by tri-
parental mating. E. coli HB101 pRK600 was used as helper strain in all conjugations. 
E. coli strains (donor and helper strain) and B. cenocepacia (recipient strain) were 
grown in LB overnight with agitation (220 rpm) at 37 °C. The donor and helper strain 
were mixed and incubated at room temperature for 10 minutes before the donor 
strain was added. The bacterial mixture was then spotted on LB agar plates and 
incubated at 37 °C for 4 to 7 hours, washed off with saline (0.9 % NaCl solution) and 
plated on Pseudomonas Isolation Agar (PIA ;BDTmDifco, USA) containing the 
respective antibiotic and incubated overnight at 37 °C. Colonies were picked, 
patched on PIA containing the respective antibiotic and again incubated overnight at 
37 °C. Successful transconjugation was confirmed by PCR with the plasmid specific 
primers listed in Table 12.  
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Bacterial genetics 
B. cenocepacia H111 mutants were constructed using three different systems. 
Mutation of hamG was accomplished by single cross-over with a homologous region 
of the hamG (I35_4188) gene cloned into the pSHAFT2Gm plasmid. An internal 
fragment of hamG was amplified with Phusion polymerase (New England Biolabs) 
using the primers listed in Table 12 and purified by the QIAquick gel extraction kit 
(Qiagen, Germany). The DNA fragment was digested with the respective restriction 
enzymes (indicated in table 12), purified using the QIAquick PCR purificaton kit 
(Qiagen, Germany) and subsequently cloned into pSHAFT2Gm. The resulting 
plasmid was electroporated into E. coli Top10 and the homology region was 
sequenced at Microsynth AG, Switzerland. The plasmid was subsequently 
transferred into B. cenocepacia H111 by tri-parental mating. Correct insertion into the 
chromosome was verified by PCR. 
 
Markerless mutations were either introduced using the pGPI-SceI/pDAI system or a 
FRT/Flp based system. 
Targeted unmarked deletions with the pGPI-SceI/pDAI system were carried out as 
described in the literature [254]. In brief, upstream and downstream regions 
(approximately 1 kb in size), flanking the region targeted for deletion, were amplified 
with Phusion Polymerase using the primers listed in Table 12. The PCR product was 
purified using the QIAquick gel extraction kit, digested with the enzymes indicated in 
Table 12 and purified with the QIAquick PCR purification kit. After triple ligation of 
pGPI-SceI with the two homology arms upstream and downstream of the targeted 
deletion region, the up- and downstream regions were sequenced at Microsynth AG. 
The resulting plasmid was electroporated into E. coli SY327 and subsequently 
transferred into the target strain (B. cenocepacia) by tri-parental mating. Correct 
integration of the plasmid by homologous recombination was verified by PCR. To 
stimulate a second homologous recombination event by double-strand break, 
plasmid pDAI-SceI was transferred into the target strain. The second homologous 
recombination event either restored the wildtype or deleted the sequence between 
the two flanking regions, the latter of which resulted in the desired unmarked mutant. 
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Successful mutant generation was verified by PCR. Mutations in hamA, hamB and 
hamF were introduced with the pGPI-SceI/pDAI system 
For targeted unmarked deletions with the FRT/FLP system, upstream and 
downstream regions of approximately 1 kb in size were amplified using Phusion 
Polymerase and the primers listed in Table 12. The PCR products were purified with 
the QIAquick gel extraction kit, digested with the appropriate restriction enzymes and 
again purified with the QIAquick PCR purification kit. The upstream fragment was 
cloned into plasmid pSHAFT-FRT and electroporated into E. coli CC118λpir. The 
downstream fragment was cloned into plasmid pEX-FRT and electroporated into E. 
coli MC1061. The up- and downstream fragments were sequenced at Microsynth AG. 
Both resulting plasmids were sequentially transferred into the target strain by 
conjugation. Integration of both plasmids into the chromosome via homologous 
recombination was verified by PCR. Plasmid pBBR5-FLP was introduced into the 
target strain and deletion of the targeted DNA region was verified by PCR. Mutants 
carrying the deletion were subsequently incubated on M9 minimal medium agar 
plates with 10 % sucrose as sole carbon source to enforce plasmid loss (pBBR5-
FLP). Plasmid loss was verified by sensitivity of the strain to gentamycin (20 µg/ml). 
Mutations in hamC, hamD, hamE and afcA were introduced with the FRT/FLP 
system. 
 
M9 minimal medium 
 
M9 salts (10 x) 
60 g Na2HPO4 anhydrous 
30 g KH2PO4 anhydrous 
5 g NaCl 
10 g NH4Cl 
dH2O  to a final volume of 1000 ml  
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M9 agar plates with sucrose 
90 ml dH2O  
1.5 % agar w/v 
10 % sucrose w/v 
10 ml M9 salts (10 x) 
100 µl 0,1M CaCl2 
100 µl 1M MgSO4 
 
Transcriptional lacZ fusions 
DNA fragments containing the putative promoters of the hamABCDE and hamFG 
operon were amplified with Phusion Polymerase using theprimers listed in Table 12. 
The promoter fragments were purified by the QIAquick gel extraction kit, digested 
with the restriction enzymes indicated in Table 12, purified by the QIAquick PCR 
purification kit and cloned into pSU11 [54] or pSU11Tp [63]. The resulting plasmids 
were electroporated into E. coli Top10 and subsequently transferred into the target 
strain by tri-parental mating with selection on PIA plates containing gentamycin (20 
µg/ml) for the pSU11 backbone or trimethoprim (25 µg/ml) for the pSU11Tp 
backbone.  
 
Assessment of promoter activity in liquid culture 
Promoter activity of transcriptional lacZ fusions in liquid cultures was assessed by β-
galactosidase assays as described before [255] with minor modifications. Briefly, 
bacterial cells were grown overnight in ABG minimal medium. If necessary, synthetic 
valazole resuspended in methanol was added to the cultures. To assess the 
influence of iron on promoter activity, no yeast extract was added to the ABG medium 
and the standard concentration of FeCl3 for ABG medium was replaced with higher or 
lower concentrations as indicated in the results section of this thesis. Bacterial 
overnight cultures were routinely set to an OD600 of 2, centrifuged at 16,000 rpm for 5 
minutes and resuspended in 2 ml Z-buffer. 1 ml of the bacterial suspension was used 
to determine the exact OD600 value. To permeabilize the cell membrane, 25 µl of 
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chloroform and 0.1 % SDS were added to the residual 1 ml of bacterial suspension, 
vortexed for 10 seconds and incubated at 28 °C for 10 minutes. 200 µl of o-
nitrophenyl-β-D-galactoside (ONPG) solution (4 mg/ml in Z-buffer) were added to 
each sample, vortexed briefly and incubated at room temperature. The reaction was 
stopped by the addition of 500 µl 1 M Na2CO3after the development of a satisfactory 
yellow color, or after 30 minutes if this did not occur. The samples were centrifuged at 
16,000 rpm for 10 minutes and 1 ml of cell-debris free supernatant was used to 
measure the absorbance at 420 nm and 550 nm with a. For every β-galactosidase 
assay, a sample  containing only the growth medium was processed as described 
above and used as a blank. To determine the promoter activity in the sample, Miller 
Units were calculated with the following formula: 
1 Miller Unit = 1000*(OD420-1.75*OD550)/(t*v*OD600) 
t = reaction time in minutes 
v = volume of assayed sample in milliliters 
 
Assessment of promoter activity on agar plates 
The promoter activity was determined qualitatively on LB, ABG or Malt Extract Agar 
(MEA ; BDTm Difco) plates containing 40 µg/ml 5-Bromo-4-chloro-3-indoxyl-beta-D-
galactopyranoside (X-Gal; Gold Biotechnology, USA). Blue coloration of the bacterial 
colonies indicated promoter activity.  
To determine the production of signaling molecules and their ability to induce 
promoter activity in reporter strains, the reporter strain was streaked next to the 
bacterial strain to be tested on LB, ABG or MEA plates containing 40 µg/ml X-Gal. 
Blue coloration of the reporter strain indicated production of a diffusible signaling 
molecule by the tested bacterial strain.  
 
Preparation for RNAseq analysis 
Starter cultures of B. cenocepacia strains for RNA extraction were setup in 5 ml LB 
broth and incubated overnight at 37 °C with agitation (220 rpm).  
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50 ml ABG aliquots were inoculated from the starter cultures to OD600 of 0.03 and 
incubated at 37 °C with shaking (220 rpm). Synthetic valazole resuspended in 
methanol was added to a final concentration of 100 µM when appropriate. An equal 
volume of methanol was added to all cultures not containing synthetic valazole. All 
strains were grown to an OD600 of 0.9 to 1. 50 ml Falcon tubes containing 5 ml stop 
solution (10 % phenol buffered with 10 mMTris-HCl pH 8) were kept on ice and 45 ml 
of bacterial cultures were added and mixed by inversion. Bacterial cells were pelleted 
by centrifugation (5,000 rpm, 15 minutes at 4 °C), the supernatant was decanted and 
the cell pellet was flash frozen using liquid nitrogen. Cells were stored at – 80 °C.  
RNA isolation and cDNA synthesis was carried out by Dr.Yilei Liu as described 
previously [256]. RNA sequencing was carried out at the Functional Genomics 
Center Zurich. RNAseq data analysis was performed byDr. Gabriella Pessi and 
Martina Lardi with the DESeq software [257]. 
 
6.3 Chemical methods 
Extraction of fragin and valazole 
Bacterial strains were grown in ABG minimal medium containing 0.005 % yeast 
extract for 72 hours with agitation (220 rpm) at 37 °C. Bacterial cultures were 
centrifuged at 5000 rpm with an Eppendorf Centrifuge 5804R. To remove all bacterial 
cells, supernatants were subsequently filtered with a Millipore ExpressTm Plus 0.22 
µm system. To extract fragin, the cell free supernatant was extracted twice with 0.5 
volumes chloroform in a separation funnel. The two chloroform phases were 
combined, dried with anhydrous magnesium sulfate (Sigma-Aldrich, Switzerland) and 
filtered through folded filters (grade: 3 hw; Sartorius, Switzerland). Alternatively, 
bacterial cells from an overnight culture grown in LB were spotted on MEA plates 
covered with a cellophane membrane (Sigma-Aldrich, Switzerland) for 7 days. 
Bacteria were removed together with the cellophane membrane and the agar plates 
were cut into small pieces. The agar pieces were mixed with an equal volume of 
chloroform and extractedfor 2h at room temperature in the dark with 90 rpm shaking 
in a glass bottle. The chloroform phase was decanted, filtered through folded filters, 
dried using anhydrous magnesium sulphate and again filtered through folded filters. 
The chloroform extracts were stored at 4 °C. 
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To extract valazole, the cell free supernatant was alkalised to pH11with 10M NaOH 
and extracted twice with 0.5 volumes dichloromethane. The dichloromethane phases 
were discarded and the water phase was subsequently acidified to pH 5 with 10 M 
HCl and extracted twice with 0.5 volumes dichloromethane. The two dichloromethane 
phases were combined, dried using anhydrous magnesium sulphate and filtered 
through a folded filter. The dichloromethane extracts were stored at 4 °C. 
Chloroform and dichloromethane extracts were dried using an Eppendorf 
Concentrator 5301 under vacuum and routinely resuspended in 0.01 volumes 
methanol. The concentrated extracts were stored at -20 °C.  
 
Thin layer chromatography (TLC) of fragin and valazole 
Concentrated fragin or valazole extracts were spotted on TLC silica gel 60 F254 plates 
(Merck Millipore, Germany). For separation of fragin, a mixture of 
chloroform:methanol (8:2) was used as mobile phase. For separation of valazole, a 
mixture of chloroform:methanol (3.5 :6.5) with 1 % triethylamine (TEA ; Sigma-
Aldrich, Switzerland) was used as mobile phase. The TLC chambers were allowed to 
become saturated with mobile phase vapour for 30 minutes before the start of TLC.  
Separation was stopped when the mobile phase had reached approximately 2 cm 
below the upper edge of the TLC plate. The TLC plates were dried at room 
temperature for at least 2 hours to ensure complete evaporation of the mobile phase. 
After separation, fragin was extracted from TLC plates for subsequent mass 
spectrometry analysis. For extraction from TLC plates, the stationary phase was 
scraped off the TLC plate, mixed with methanol and vortexed for 1 hour at room 
temperature. After centrifugation (13,000 rpm, 1 minute), the clear methanol 
supernatant was removed and stored at 4 °C.  
 
TLC overlay assays 
To visualize valazole, TLC plates were overlayed with top-agar (ABG with 0.4 % 
agar) containing the appropriate reporter strain and 40 µg/ml X-Gal. The overlayed 
TLC plates were incubated in a wet chamber at 37 °C until clear blue spots, 
indicating the presence of the signaling molecule (valazole), developed. The agar 
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was subsequently dried at room temperature for 2 days and pictures were taken with 
a Nikon D90 camera with AF-S Micro Nikkor 60 mm objective. 
 
6.4 Phenotypic assays 
Dual culture plate assay. 
Bacteria from overnight LB cultures were pelleted, washed and resuspended to an 
OD600 of 1. Between 10 or 20 µl of bacterial suspension were spotted at three points 
at the edge of the MEA plates, equidistant from the center and each other, and the 
suspension was allowed to dry for 10 minutes. The spotted bacteria were incubated 
overnight at 37 °C. Fungi were prepared by placing a fungal plug in the middle of a 
MEA plate. After 3 days (Rhizoctonia solani) or 8 days (Fusarium solani), plugs from 
the edge of the plates were taken and placed placed in the center of the MEA plates 
with the spotted bacteria. The plates were sealed with parafilm and incubated at 
room temperature in the dark. Plates with the fungus F. solani were incubated for 8 
days and plates with the fungus R. solani, were incubated for 3 days. MEA plates 
with fungal plugs but lacking bacteria were used as controls to determine fungal 
growth. Pictures were taken with a Nikon D90 camera with AF-S Micro Nikkor 60 mm 
objective and used to determine the antifungal activity of each bacterial strain. The 
fungal surface area (mm2) was calculated from pictures using the ImageJ software. 
Antifungal activity was calculated by subtracting the fungal surface area (mm2) from 
plates grown with bacteria from the fungal surface (mm2) area of control plates. 
 
Fungal spray assay 
One agar plug of F. solani was incubated in LB with 70 rpm shaking at room 
temperature for 2 to 3 days. The liquid F. solani culture was homogenised with glass 
beads by thorough vortexing.  
Bacterial strains to be tested were grown overnight at 37 °C with 220 rpm shaking, 
resuspended to an OD600 of 1 and 10 or 20 µl of the bacterial suspension were 
spotted on MEA plates. After preincubation of the spotted bacteria at 37 °C for 20 
hours, the homogenized fungus was sprayed on the MEA plates with a perfume 
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spray bottle purchased at a supermarket. The plates were sealed with parafilm and 
incubated in the dark at room temperature for 48 hours. Antifungal activity of the 
bacterial strains resulted in a fungus-free halo around the bacterial colony. Pictures 
were taken with a Nikon D90 camera with a AF-S Micro Nikkor 60 mm objective. 
 
Siderophore production 
Bacteria were screened for the production of metal chelating molecules on Chrome 
Azurol S (CAS) agar plates as  described by Schwyn and Neilands[258]. Briefly, 
bacterial cultures grown overnight in either LB or ABG medium were resuspended to 
an OD600 of 1 and 10 µl were spotted on CAS agar plates and incubated at 37 °C 
overnight. CAS agar plates were examined for an orange or yellow halo around the 
bacterial cultures which indicated the production and secretion of iron chelating 
molecules. Pictures were taken with a Nikon D90 camera with AF-S Micro Nikkor 60 
mm objective. 
 
EPS production 
Bacteria were screened for EPS production on YEM agar plates (yeast extract 0.05 
%; mannitol 0.4 %, agar 1.5 %). Bacteria were grown overnight in LB or ABG 
medium, then resuspended to an OD600 of 1 and streaked on YEM agar plates in a 
cross shape. After incubation at 37 °C for 2 days, the bacteria were examined for 
EPS production. Pictures were taken with a Nikon D90 camera with AF-S Micro 
Nikkor 60 mm objective. 
 
Protease production 
Bacteria were screened for protease production on skim milk LB agar plates. In brief, 
bacteria were grown overnight in LB or ABG medium, then resuspended to an OD600 
of 1 and 10 µl of the bacterial cultures were spotted on skim milk agar plates (LB 
agar plates with 2 % w/v skim milk). The bacteria were incubated for 2 days at 37 °C 
and then screened for a clear halo around the bacterial colonies, which denoted the 
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production and secretion of proteases. Pictures were taken with a Nikon D90 camera 
with AF-S Micro Nikkor 60 mm objective. 
 
6.5 Transposon mutagenesis 
Preparation of a transposon mutant library 
To construct a pooled transposon library, the donor strain (E. coli S17/pUT-miniTn5) 
and the recipient strain (B. cenocepacia H111) were grown to mid-log phase. To 
mobilize pUT-miniTn5 into the recipient strain multiple parallel conjugations were 
setup. 100 µl donor strain were mixed with 200 µl recipient strain and spotted in 50 µl 
aliquots on LB agar plates and incubated overnight at 37 °C. The bacterial mix was 
washed off with saline and the bacterial mixtures from all parallel conjugations were 
pooled and plated on PIA plates containing 100 µg/ml kanamycin. After overnight 
incubation at 37 °C, colonies were counted, washed off the plates with saline and 
mixed with 0.33 volume 50 % glycerol. The transposon library was aliquoted (1 ml 
per aliquot) and stored at -80 °C.  
 
Screening for transposon mutants deficient in yellow colony 
formation/antifungal activity 
One aliquot of the pooled transposon library was regenerated in 8 ml LB for 30 
minutes at 50 rpm agitation at 37 °C, centrifuged at 5,000 rpm and resuspended in 
10 ml saline. The bacteria were subsequently diluted to allow the growth of single 
colonies on agar plates. The diluted bacteria were plated on MEA plates containing 
100 µM FeCl3 and incubated for 24 hours. Colonies showing either a white or bright 
yellow colony phenotype were patched on a new MEA plate containing 100 µM FeCl3 
to confirm the phenotype. Clones which showed a consistent phenotype were used 
for further investigation and the transposon insertion site was mapped by arbitrary 
PCR.  
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Mapping of the transposon insertion site 
Selected clones from the transposon mutant library were lysed by heating at 90 °C in 
a thermocycler and the transposon insertion site was mapped by arbitrary PCR. 
Primers used for the arbitrary PCR are listed in Table 12.  
 
1st round PCR: 
- PCR reaction mix: 
o DNA (from lysed colony) 5 µl 
o dNTPs (10 mM each) 2  µl 
o 5xbuffer (GoTaqFlexi) 10  µl 
o DMSO 4 µl 
o MgCl2 (25 mM) 6  µl 
o ARB6 (50 µM) 4  µl 
o specific internal (5 µM) 4  µl 
o GoTaq (Promega) 0.5  µl 
o MQ H2O 14.5 µl 
- Thermocycler program:  
o 95°C  5  min 
o 95°C 0.5  min 
o 30°C 0.5 min 
o 72°C 1 min 
o 95°C 0.5  min 
o 45°C 0.5 min 
o 72°C 1 min 
o 72°C 5 min 
o 12°C forever 
- Purification of PCR product with QIAquick PCR purification kit (Qiagen). 
 
  
6 x 
30x 
Chapter IV: Material and Methods 
106 
 
2nd round PCR: 
- PCR reaction mix: 
o  purified 1st round PCR product5 µl 
o dNTPs (10 mM each) 2  µl 
o 5xbuffer (GoTaq, Flexi) 10  µl 
o DMSO 4 µl 
o MgCl2 (25 mM) 6  µl 
o ARB2 (50 µM) 4  µl 
o specific external (5 µM) 4  µl 
o GoTaq (Promega) 0.5  µl 
o MQ H2O 14.5 µl 
- Thermocycler program:  
o 95°C  5  min 
o 95°C 0.5  min 
o 50°C 0.5 min 
o 72°C 1 min 
o 72°C 5 min 
o 12°C Hold 
 
The PCR products were separated on a 0.8 % agarose gel. Bands were cut out from 
the gel, purified using the QIAquick gel extraction kit (Qiagen) and sequenced at 
Microsynth AG. If multiple bands were derived from a single arbitrary PCR reaction, 
all bands were sequenced separately.  
  
30 x 
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Table 11: Bacterial strains and plasmids used in this study 
Strain or plasmid Characteristics/Information Source/Reference 
Burkholderia 
 
  
H111 CF isolate, (Germany) [43] 
H111 ∆cepIR Unmarked deletion of a region 
spanning from cepI to cepR 
Straincollection Eberl lab 
H111 ΔhamA unmarked hamA deletion mutant This study 
H111 ΔhamB unmarked hamB deletion mutant This study 
H111 ΔhamC unmarked hamC deletion mutant This study 
H111 ΔhamD unmarked hamD deletion mutant This study 
H111 ΔhamE unmarked hamE deletion mutant This study 
H111 ΔhamF unmarked hamF deletion mutant This study 
H111 hamG ::pSH hamG interrupted by pSHAFT2Gm 
insertion 
This study 
H111 ΔpchAB unmarked pchAB deletion mutant [259] 
H111 ΔorbJ unmarked orbJ deletion mutant [259] 
H111 ΔpchAB ΔorbJ unmarked pchAB and orbJ double 
deletion mutant 
[259] 
H111 ΔpC3 H111 after loss of megaplasmid 
pC3 
[110] 
H111 cepR2::pEX18 cepR2 interrupted by pEX18Gm 
insertion 
[54] 
H111 cepS::Tn5 H111 transposon mutant with cepS 
interrupted 
This study 
H111 lysR ::Tn5 H111 transposon mutant with 
I35_0679 interrupted 
This study 
H111 araC ::Tn5 H111 tarnsposon mutant with 
I34_4197 interrupted  
This study 
K56-2 CF sputum isolate, (Canada) ; 
ET12 lineage 
[252] 
K56-2 ΔcepR2 cepR2 interrupted by trimethoprim 
cassette ; TpR 
Sokol lab 
   
Escherichia coli   
Top 10 
F- mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 nupG 
recA1 araD139 Δ(ara-leu)7697 
galE15 galK16 rpsL(StrR) endA1 λ- 
Invitrogen 
CC118λpir Δ(ara,leu)7697 araD139 ΔlacX74 
galE galK phoA20 thi-1 rpsE 
rpoB(RFR) argE(am) recA1 λpir+ 
[260] 
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MC1061 hsdR araD139 Δ(ara-leu)7697 
ΔlacX74 galU galK rpsL (SmR) 
[261] 
SY327 araD Δ(lac pro) argE(am) recA56 
RifR nalA λpir 
[262] 
DH5α F
-Φ80dlacZΔM15 Δ(lacZYA-
argF)U169 recA1 endA1 hsdR17 (rK-, 
mK+) supE44 thi-1 relA1 gyrA96 
[253] 
ATCC25922 recomended reference strain for 
antibiotic susceptibility testing 
ATCC® 
K-12  F- λ- rph-1 ilvG- rfb-50; MG1655 Straincollection Eberl lab 
S17 thi recA pro hsdR- hsdM+ RP4-2-
Tc::Mu-Km::Tn7 
[263] 
HB101 recA thi pro leu hsd M+ ; SmR [264] 
   
Additional bacteria   
Klebsiella oxytoca wild type Straincollection Eberl lab 
Bacillus cereus wild type Straincollection Eberl lab 
Bacillus thuringiensis wild type Straincollection Eberl lab 
Staphylococcus aureus wild type Straincollection Eberl lab 
Pseudomonas syringae 
   
Bean pathogen; RifR [265] 
Chromobacterium 
 
wild type Straincollection Eberl lab 
   
Yeast   
Saccharomyces cerevisae 
BY4741 
MATa his3Δ1 leu2Δ0 met15Δ0 
ura3Δ0 
Undine Krügel, 
Grossniklaus lab 
   
   
Plasmids   
pBBR pBBR1MCS2 ; expression vector [266] 
pSU11 vector for lacZ fusion [267] 
pSU11Tp pSU11 carrying a trimethoprim 
resistance 
[63] 
pEX ::FRT pEX18TP containing a FRT site ; 
GmR 
Kirsty Agnoli, Eberl lab 
pSHAFT ::FRT 
pUTmini-Tn5Cm with deleted BglII 
fragment; contains the tnp gene 
and I end of mini-Tn5; containig a 
FRT site ; CmR 
Kirsty Agnoli, Eberl lab 
pBBR5-FLP pBBR1MCS5 encoding flippase [110] 
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pSHAFT2Gm pUTmini-Tn5Cm with deleted BglII 
fragment; contains the tnp gene 
and I end of mini-Tn5; GmR 
[268] 
pDAI-SceI pDAI17 carrying the I-SceI gene [254] 
pGPI-SceI pGPI-SceI from [254] with TpR 
   
Elisabeth Steiner, Eberl 
 pRK600 RK2-mob
+ RK2-tra+, ori ColE1 [269] 
pUT-miniTn5 transposon delivery vector [260] 
pBBRhamA pBBR1MCS2 expressing hamA This study 
pBBRhamB pBBR1MCS2 expressing hamB This study 
pBBRhamC pBBR1MCS2 expressing hamC This study 
pBBRhamD pBBR1MCS2 expressing hamD This study 
pBBRhamE pBBR1MCS2 expressing hamE This study 
pBBRhamF pBBR1MCS2 expressing hamF This study 
pBBRhamG pBBR1MCS2 expressing hamG This study 
PhamA-lacZ pSU11 containing the full hamA 
  
This study 
PhamA122-lacZ pSU11 containing 122 bp of the 
   
This study 
PhamA222-lacZ pSU11 containing 222 bp of the 
   
This study 
PhamA281-lacZ pSU11 containing 281 bp of the 
   
This study 
PhamF-lacZ pSU11 containing the full hamF 
  
This study 
PhamA-lacZTp pSU11Tp containing the full hamA 
  
This study 
PhamF-lacZTp pSU11Tp containing the full hamF 
  
This study 
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Table 12: Oligonucleotides used in this study (nucleotide sequences of restriction sites are 
underlined). 
Primer Sequence (5`-3`) restrict
ion site 
hamA mutant   
hamA_SceI_up_rv ggggccatggCTCCAGCCCTTCCAGTTGA NcoI 
hamA_SceI_up_fw ggggtctagaCGCGTCTTCGTCCAGTT XbaI 
hamA_SceI_d_fw ggggccatggGATGCGATCGACGAG NcoI 
hamA_SceI_d_rv gggggaattcATCCAGAACGCCGAG EcoRI 
   
hamB mutant   
hamB_SceI_up_fw ggggtctagaAGGAGAGTCCCGTGAATCAA XbaI 
hamB_SceI_up_rv ggggccatggTATCGACGAGCACGACCTG NcoI 
hamB_SceI_d_fw ggggccatggTGCTGCTCGAAATCCATTACT NcoI 
hamB_SceI_d_rv gggggaattcAAGAACTGCCGGATGTTGAC EcoRI 
   
hamC mutant   
hamC_FRT_u_rv ggggagatctTAGTAGCGCAGTTCGTCGT BglII 
hamC_FRT_u_fw ggggagatctGGATTTCATGTCGCTCGT BglII 
hamC_FRT_d_fw ggggggatccTGAGTCACGTCGATGAA BamHI 
hamC_FRT_d_rv gggggaattcAGGTCGGGAACATGTC EcoRI 
   
hamD mutant   
hamD_FRT_down_f
w 
ggggctcgagCGTACCCCGTTTGATCAAT PstI 
hamD_FRT_down_r
v 
ggggggatccGCGTATCACGAGCGCAT BamHI 
hamD_FRT_up_fw ggggctcgagATCGGGAAGGCAGCTACT XhoI 
hamD_FRT_up_rv ggggagatctttagCCGCCGATCGCAATGAT BglII 
   
hamE mutant   
hamE_FRT_u_fw ggggctcgagCTTCTTGGGCAGCTTCATC XhoI 
hamE_FRT_u_rv ggggctcgagGATGAATGATGCGATGACAG XhoI 
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hamE_FRT_d_fw ggggctcgagTCAAGCCGCAGTAACCGT PstI 
hamE_FRT_d_rv gggggaattcCCAGCCGGAGGTTTCGTTA EcoRI 
   
hamF mutant   
hamF_SceI_up_fw ggggtctagaCGTGCAGGTACAGGTCGTAG XbaI 
HamF_SceI_up_rv ggggccatggCACGTCGTTTCTCCTGGAA NcoI 
hamF_SceI_d_fw ggggccatggTTCCTGACTTTCATGCGTGT NcoI 
hamF_SceI_d_rv gggggaattcACCCTGGAACAGGATCTCG EcoRI 
   
hamG mutant   
hamG_ins_fw ggggtctagaATCGGGACCCTGGAACA XbaI 
hamG_ins_rv ggggctcgagGGCGGGAAATCAAGGAA XhoI 
   
hamA expression   
hamA_expr_fw ggggaagcttctaaCGAGCGGACATTACTAGGAGA HindIII 
hamA_expr_rv ggggtctagattagcTATCGACGAGCACGACCTG XbaI 
   
hamB expression   
hamB_expr_fw ggggaagcttctaaTAGGAGATGCCGGCATGAACG HindIII 
hamB_expr_rv ggggtctagattatGGGTAGTAGCGCAGTTCGTC XbaI 
   
hamC expression   
hamC_expr_fw ggggctcgagctaaCCATTACTACGGTTCCCC XhoI 
hamC_expr_rv_Xba
I 
ggggtctagaCTCACAGGTAGTCGGACA XbaI 
   
hamD expression   
hamD_expr_fw ggggaagcttctaaTGTCCGACTACCTGTGAG HindIII 
hamD_expr_rv ggggtctagaATCAAACGGGGTACGTC XbaI 
   
hamE expression   
hamE_expr_fw ggggctcgagctaaGTCATCGCATCATTCATCAAG XhoI 
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hamE_expr_rv ggggtctagaCGGTTACTGCGGCTTGA XbaI 
   
hamF expression   
hamF_expr_fw ggggaagcttctaaTGCCCCGTCAAACCGAAT HindIII 
hamF_expr_rv ggggtctagaGCCGACGAACTGAGCGAACT XbaI 
   
hamG expression   
hamG_expr_fw ggggaagcttctaaCCAGGAGAAACGACGTGA HindIII 
hamG_expr_rv ggggtctagaTGATTCGGTTTGACGGGG XbaI 
   
lacZ fusions   
hamA_prom_fw ggggctcgagGCGGACAGCGGCAATTGAA XhoI 
hamA_prom122_fw ggggctcgagATCGACGCCTGAAATTGCT XhoI 
hamA_prom222_fw ggggctcgagCATGACGGTAAAGGCTTTGG XhoI 
hamA_prom281_fw ggggctcgagTAGACAGCCCGATTTG XhoI 
hamA_prom_rv ggggaagcttaCTCCAGCCCTTCCAGTTGA HindIII 
hamF_prom_fw ggggctcgaGCTCCAGCCCTTCCAGTT XhoI 
hamF_prom_rv ggggaagcttaGGACAGCGGCAATTGAA HindIII 
   
afcA mutant   
afcA_FRT_up_fw ggggctcgagGATAGTTGTTGCCGTTCGTGA XhoI 
afcA_FRT_up_rv ggggagatctttaCAGGCGGTGAATGGTGGAA BglII 
afcA_FRT_d_rv ggggggatccATAGTCGAAGAAGCCGGG BamHI 
afcA_FRT_d_fw gggggaattcAGGATCTGTGTTTCGTCGAG EcoRI 
   
transposon 
mutagenesis 
  
ARB6 GGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC  
specific internal GACCTTGCC ATC ATGACTGTGCTG  
ARB2 GGC CACGCGTCGACTAGTAC  
specific external AAC GCGTATTCAGGCTGACC  
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arb-seq ATG AATGTTCCGTTGCGCTG  
   
plasmid specific   
pSHAFTseq_fw4 GAACACTTAACGGCTGACAT  
pSHAFTFor2 AAGGTGACCGCGTATTATTA  
M13 fw (-21) TGTAAAACGACGGCCAGT  
lacZrv TGCTGCAAGGCGATTAAG  
pSU11trm_rv GTGCTGCAAGGCGATTAAGT  
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